# EDGAR Filing Document

**Accession Number:** 0001043337
**File Stem:** 0001043337-26-000052
**Filing Date:** 2026-5
**Character Count:** 173318
**Document Hash:** fac36158d9732c4f3a99e6b801373ed4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001043337-26-000052.hdr.sgml**: 20260515

**ACCESSION NUMBER**: 0001043337-26-000052

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 77

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260515

**DATE AS OF CHANGE**: 20260515

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** STONERIDGE INC
- **CENTRAL INDEX KEY:** 0001043337
- **STANDARD INDUSTRIAL CLASSIFICATION:** MOTOR VEHICLE PARTS & ACCESSORIES [3714]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 341598949
- **STATE OF INCORPORATION:** OH
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-13337
- **FILM NUMBER:** 26989345

**BUSINESS ADDRESS:**
- **STREET 1:** 39675 MACKENZIE DRIVE
- **STREET 2:** SUITE 400
- **CITY:** NOVI
- **STATE:** MI
- **ZIP:** 48377
- **BUSINESS PHONE:** 2484899300

**MAIL ADDRESS:**
- **STREET 1:** 39675 MACKENZIE DRIVE
- **STREET 2:** SUITE 400
- **CITY:** NOVI
- **STATE:** MI
- **ZIP:** 48377

?xml version='1.0' encoding='ASCII'? sri-20260331

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

⌧**QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarter ended March 31, 2026**

**or**

□**TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**Commission file number: 001-13337**

![999.jpg](sri-20260331_g1.jpg)

**<u>STONERIDGE, INC.</u>**

*(Exact name of registrant as specified in its charter)*

---

| | |
|:---|:---|
| **Ohio** | **34-1598949** |
| *(State or other jurisdiction of<br>incorporation or organization)* | *(I.R.S. Employer<br>Identification No.)* |
| **39675 MacKenzie Drive, Suite 400, Novi, Michigan** | **48377** |
| *(Address of principal executive offices)* | *(Zip Code)* |

---

---

| |
|:---|
| **(248) 489-9300** |
| *Registrant's telephone number, including area code* |

---

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common Shares, without par value  | SRI | New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

⌧Yes □No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

⌧Yes □No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer □ Accelerated filer ⌧ Non-accelerated filer □ <br> Smaller reporting company □ Emerging growth company □

If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period &nbsp;&nbsp;&nbsp;&nbsp;for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. □

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). □Yes ⌧No

The number of Common Shares, without par value, outstanding as of May 11, 2026 was 28,235,245.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC. AND SUBSIDIARIES**

---

| | | |
|:---|:---|:---|
| **INDEX** | | **Page** |
| <u>[PART I–FINANCIAL INFORMATION](#if930f674aeb44051bc7e87b8feb3c2eb_13)</u> | <u>[PART I–FINANCIAL INFORMATION](#if930f674aeb44051bc7e87b8feb3c2eb_13)</u> |  |
| <u>[Item 1.](#if930f674aeb44051bc7e87b8feb3c2eb_16)</u> | <u>[Financial Statements](#if930f674aeb44051bc7e87b8feb3c2eb_16)</u> |  |
|  | <u>[Condensed Consolidated Balance Sheets as of March 31, 2026 (Unaudited) and December 31, 2025](#if930f674aeb44051bc7e87b8feb3c2eb_19)</u> | [4](#if930f674aeb44051bc7e87b8feb3c2eb_19) |
|  | <u>[Condensed Consolidated Statements of Operations (Unaudited) for the Three Months Ended March 31, 2026 and 2025](#if930f674aeb44051bc7e87b8feb3c2eb_22)</u> | [5](#if930f674aeb44051bc7e87b8feb3c2eb_22) |
|  | <u>[Condensed Consolidated Statements of Comprehensive (Loss) Income (Unaudited) for the Three Months Ended March 31, 2026 and 2025](#if930f674aeb44051bc7e87b8feb3c2eb_25)</u> | [6](#if930f674aeb44051bc7e87b8feb3c2eb_25) |
|  | <u>[Condensed Consolidated Statements of Cash Flows (Unaudited) for the Three Months Ended March 31, 2026 and 2025](#if930f674aeb44051bc7e87b8feb3c2eb_31)</u> | [7](#if930f674aeb44051bc7e87b8feb3c2eb_31) |
|  | <u>[Condensed Consolidated Statements of Shareholders' Equity (Unaudited) for the Three Months Ended March 31, 2026 and 2025](#if930f674aeb44051bc7e87b8feb3c2eb_34)</u> | [8](#if930f674aeb44051bc7e87b8feb3c2eb_34) |
|  | <u>[Notes to Condensed Consolidated Financial Statements (Unaudited)](#if930f674aeb44051bc7e87b8feb3c2eb_37)</u> | [9](#if930f674aeb44051bc7e87b8feb3c2eb_37) |
| <u>[Item 2.](#if930f674aeb44051bc7e87b8feb3c2eb_118)</u> | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#if930f674aeb44051bc7e87b8feb3c2eb_118)</u> | [27](#if930f674aeb44051bc7e87b8feb3c2eb_118) |
| <u>[Item 3.](#if930f674aeb44051bc7e87b8feb3c2eb_160)</u> | <u>[Quantitative and Qualitative Disclosures About Market Risk](#if930f674aeb44051bc7e87b8feb3c2eb_160)</u> | [35](#if930f674aeb44051bc7e87b8feb3c2eb_160) |
| <u>[Item 4.](#if930f674aeb44051bc7e87b8feb3c2eb_163)</u> | <u>[Controls and Procedures](#if930f674aeb44051bc7e87b8feb3c2eb_163)</u> | [35](#if930f674aeb44051bc7e87b8feb3c2eb_163) |
| <u>[PART II–OTHER INFORMATION](#if930f674aeb44051bc7e87b8feb3c2eb_166)</u> | <u>[PART II–OTHER INFORMATION](#if930f674aeb44051bc7e87b8feb3c2eb_166)</u> |  |
| <u>[Item 1.](#if930f674aeb44051bc7e87b8feb3c2eb_169)</u> | <u>[Legal Proceedings](#if930f674aeb44051bc7e87b8feb3c2eb_169)</u> | [36](#if930f674aeb44051bc7e87b8feb3c2eb_169) |
| <u>[Item 1A.](#if930f674aeb44051bc7e87b8feb3c2eb_172)</u> | <u>[Risk Factors](#if930f674aeb44051bc7e87b8feb3c2eb_172)</u> | [36](#if930f674aeb44051bc7e87b8feb3c2eb_172) |
| <u>[Item 2.](#if930f674aeb44051bc7e87b8feb3c2eb_175)</u> | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#if930f674aeb44051bc7e87b8feb3c2eb_175)</u> | [36](#if930f674aeb44051bc7e87b8feb3c2eb_175) |
| <u>[Item 3.](#if930f674aeb44051bc7e87b8feb3c2eb_178)</u> | <u>[Defaults Upon Senior Securities](#if930f674aeb44051bc7e87b8feb3c2eb_178)</u> | [36](#if930f674aeb44051bc7e87b8feb3c2eb_178) |
| <u>[Item 4.](#if930f674aeb44051bc7e87b8feb3c2eb_181)</u> | <u>[Mine Safety Disclosures](#if930f674aeb44051bc7e87b8feb3c2eb_181)</u> | [36](#if930f674aeb44051bc7e87b8feb3c2eb_181) |
| <u>[Item 5.](#if930f674aeb44051bc7e87b8feb3c2eb_184)</u> | <u>[Other Information](#if930f674aeb44051bc7e87b8feb3c2eb_184)</u> | [36](#if930f674aeb44051bc7e87b8feb3c2eb_184) |
| <u>[Item 6.](#if930f674aeb44051bc7e87b8feb3c2eb_187)</u> | <u>[Exhibits](#if930f674aeb44051bc7e87b8feb3c2eb_187)</u> | [37](#if930f674aeb44051bc7e87b8feb3c2eb_187) |
| <u>[Signatures](#if930f674aeb44051bc7e87b8feb3c2eb_190)</u> | <u>[Signatures](#if930f674aeb44051bc7e87b8feb3c2eb_190)</u> | [38](#if930f674aeb44051bc7e87b8feb3c2eb_190) |

---

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**Forward-Looking Statements**

Portions of this report on Form 10-Q contain "forward-looking statements" under the Private Securities Litigation Reform Act of 1995. These statements appear in a number of places in this report and may include statements regarding the intent, belief or current expectations of the Company, with respect to, among other things, our (i) future product and facility expansion, (ii) strategic focus following the sale of the Control Devices segment, (iii) acquisition strategy, (iv) investments and new product development, (v) growth opportunities related to awarded business, and (vi) operational expectations. Forward-looking statements may be identified by the words "will," "may," "should," "could," "would," "designed to," "believes," "plans," "projects," "intends," "expects," "estimates," "anticipates," "continue," and similar words and expressions. The forward-looking statements are subject to risks and uncertainties that could cause actual events or results to differ materially from those expressed in or implied by these statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, among other factors:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the ability of our suppliers to supply us with parts and components at competitive prices on a timely basis, including the impact of potential tariffs and trade considerations on their operations and output;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• fluctuations in the cost and availability of key materials and components (including semiconductors, printed circuit boards, resin, aluminum, steel and copper) and our ability to offset cost increases through negotiated price increases with our customers or other cost reduction actions, as necessary;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• global economic trends, competition and geopolitical risks, including impacts from ongoing or potential global conflicts and any related sanctions and other measures, or an escalation of sanctions, tariffs or other trade tensions between the U.S. and other countries;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• tariffs specifically in countries where we have significant direct or indirect manufacturing or supply chain exposure and our ability to either mitigate the impact of tariffs or pass any incremental costs to our customers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to achieve cost reductions that offset or exceed customer-mandated selling price reductions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the reduced purchases, loss, financial distress or bankruptcy of a major customer or supplier;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the costs and timing of business realignment, facility closures or similar actions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a significant change in commercial, automotive, off-highway or agricultural vehicle production;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• competitive market conditions and resulting effects on sales and pricing;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• foreign currency fluctuations and our ability to manage those impacts;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• customer acceptance of new products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to successfully launch/produce products for awarded business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• adverse changes in laws, government regulations or market conditions affecting our products, our suppliers, or our customers' products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our ability to protect our intellectual property and successfully defend against assertions made against us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• liabilities arising from warranty claims, product recall or field actions, product liability and legal proceedings to which we are or may become a party, or the impact of product recall or field actions on our customers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• labor disruptions at our facilities, or at any of our significant customers or suppliers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• business disruptions due to natural disasters or other disasters outside of our control;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the amount of our indebtedness and the restrictive covenants contained in the agreements governing our indebtedness, including our revolving credit facility;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• capital availability or costs, including changes in interest rates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• refinancing risk and access to capital markets and liquidity;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the failure to achieve the successful integration of any acquired company or business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks related to a failure of our information technology systems and networks, and risks associated with current and emerging technology threats and damage from computer viruses, unauthorized access, cyber-attack and other similar disruptions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• as a result of the sale of the Company's Control Devices business in January 2026, the Company will operate as a two-segment business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the items described in Part I, Item 1A ("Risk Factors") in the Company's 2025 <u>[Form 10-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/1043337/000104333726000023/sri-20251231.htm)</u>.

The forward-looking statements contained herein represent our estimates only as of the date of this filing and should not be relied upon as representing our estimates as of any subsequent date. While we may elect to update these forward-looking statements at some point in the future, except as required by law, we specifically disclaim any obligation to do so, whether to reflect actual results, changes in assumptions, changes in other factors affecting such forward-looking statements or otherwise.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**PART I – FINANCIAL INFORMATION**

**Item 1. Financial Statements**

**STONERIDGE, INC.**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

---

| | | |
|:---|:---|:---|
| **(in thousands)** | **March 31,<br>2026** | **December 31,<br>2025** |
| | **(unaudited)** | |
| **ASSETS** | | |
| Current assets: |  |  |
| &nbsp;&nbsp;Cash and cash equivalents | $**70536** | $53057 |
| &nbsp;&nbsp;Accounts receivable, less reserves of $296 and $325, respectively | **140151** | 89019 |
| &nbsp;&nbsp;Inventories, net | **111252** | 106422 |
| &nbsp;&nbsp;Prepaid expenses and other current assets | **26061** | 26956 |
| &nbsp;&nbsp;Current assets of discontinued operations | **—** | 86342 |
| Total current assets | **348000** | 361796 |
| &nbsp;&nbsp;Long-term assets: |  |  |
| &nbsp;&nbsp;Property, plant and equipment, net | **60231** | 62659 |
| &nbsp;&nbsp;Intangible assets, net | **35509** | 37632 |
| &nbsp;&nbsp;Goodwill | **36959** | 37590 |
| &nbsp;&nbsp;Operating lease right-of-use asset | **9020** | 9570 |
| &nbsp;&nbsp;Investments and other long-term assets, net | **22252** | 22167 |
| &nbsp;&nbsp;Long-term assets of discontinued operations | **—** | 19702 |
| Total long-term assets | **163971** | 189320 |
| Total assets | $**511971** | $551116 |
| **LIABILITIES AND SHAREHOLDERS' EQUITY** |  |  |
| &nbsp;&nbsp;Accounts payable | $**103494** | $62398 |
| &nbsp;&nbsp;Accrued expenses and other current liabilities | **69090** | 65132 |
| &nbsp;&nbsp;Current liabilities of discontinued operations | **—** | 29955 |
| Total current liabilities | **172584** | 157485 |
| &nbsp;&nbsp;Long-term liabilities: |  |  |
| &nbsp;&nbsp;Revolving credit facility | **156470** | 180942 |
| &nbsp;&nbsp;Deferred income taxes | **8730** | 9972 |
| &nbsp;&nbsp;Operating lease long-term liability | **6190** | 6601 |
| &nbsp;&nbsp;Other long-term liabilities | **11815** | 11604 |
| &nbsp;&nbsp;Long-term liabilities of discontinued operations | **—** | 4733 |
| Total long-term liabilities | **183205** | 213852 |
| &nbsp;&nbsp;Preferred Shares, without par value, 5,000 shares authorized, none issued | **—** |  |
| &nbsp;&nbsp;Common Shares, without par value, 60,000 shares authorized, 28,966 and 28,966 shares issued and 28,236 and 28,018 shares outstanding at March 31, 2026 and December 31, 2025, respectively, with no stated value | **—** |  |
| &nbsp;&nbsp;Additional paid-in capital | **215639** | 219186 |
| &nbsp;&nbsp;Common Shares held in treasury, 730 and 948 shares at March 31, 2026 and December 31, 2025, respectively, at cost | **(20341)** | (27457) |
| &nbsp;&nbsp;Retained earnings | **49233** | 77150 |
| &nbsp;&nbsp;Accumulated other comprehensive loss | **(88349)** | (89100) |
| Total shareholders' equity | **156182** | 179779 |
| Total liabilities and shareholders' equity | $**511971** | $551116 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC**.

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **Three months ended<br>March 31,** | **Three months ended<br>March 31,** |
|<br>**(in thousands, except per share data)** | **2026** | **2025** |
| Net sales | $**160847** | $149057 |
| Costs and expenses: |  |  |
| &nbsp;&nbsp;Cost of goods sold | **125891** | 113807 |
| &nbsp;&nbsp;Selling, general and administrative | **32529** | 25865 |
| &nbsp;&nbsp;Design and development | **11405** | 13691 |
| Operating loss | **(8978)** | (4306) |
| &nbsp;&nbsp;Interest expense, net | **3685** | 3242 |
| &nbsp;&nbsp;Equity in loss (earnings) of investee | **231** | (294) |
| &nbsp;&nbsp;Other expense (income), net | **470** | (825) |
| Loss before income taxes from continuing operations | **(13364)** | (6429) |
| Provision for income taxes from continuing operations | **1414** | 1575 |
| Loss from continuing operations | **(14778)** | (8004) |
| Discontinued operations: |  |  |
| &nbsp;&nbsp;Loss (income) from discontinued operations, net of tax | **3322** | (808) |
| &nbsp;&nbsp;Loss on disposal, net of tax | **9817** |  |
| Loss (income) from discontinued operations | **13139** | (808) |
| Net loss | $**(27917)** | $(7196) |
| Loss per share from continuing operations: |  |  |
| &nbsp;&nbsp;Basic | $**(0.53)** | $(0.29) |
| &nbsp;&nbsp;Diluted | $**(0.53)** | $(0.29) |
| (Loss) income per share from discontinued operations: |  |  |
| &nbsp;&nbsp;Basic | $**(0.47)** | $0.03 |
| &nbsp;&nbsp;Diluted | $**(0.47)** | $0.03 |
| Loss per share from Stoneridge Inc.: |  |  |
| Basic | $**(1.00)** | $(0.26) |
| Diluted | $**(1.00)** | $(0.26) |
| Weighted-average shares outstanding: |  |  |
| &nbsp;&nbsp;Basic | **27898** | 27680 |
| &nbsp;&nbsp;Diluted | **27898** | 27680 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME** 

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **Three months ended<br>March 31,** | **Three months ended<br>March 31,** |
|<br>**(in thousands)** | **2026** | **2025** |
| Net loss | $**(27917)** | $(7196) |
| Other comprehensive income, net of tax: |  |  |
| &nbsp;&nbsp;Foreign currency translation | **751** | 12783 |
| &nbsp;&nbsp;Unrealized gain on derivatives (1) | **—** | 1343 |
| Other comprehensive income, net of tax | **751** | 14126 |
| Comprehensive (loss) income | $**(27166)** | $6930 |

---

(1) Net of tax benefit o f $0 and $357 for the three months ended March 31, 2026 and 2025, respectively.

The Company has combined comprehensive (loss) income from continuing operations and comprehensive (loss) income from discontinued operations herein.

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| **Three months ended March 31, (in thousands)** | **2026** | **2025** |
| **OPERATING ACTIVITIES:** |  |  |
| Net loss | $**(27917)** | $(7196) |
| &nbsp;&nbsp;&nbsp;Adjustments to reconcile net loss to net cash provided by (used for) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;Loss (income) from discontinued operations | **3322** | (808) |
| &nbsp;&nbsp;&nbsp;Depreciation | **3434** | 5428 |
| &nbsp;&nbsp;&nbsp;Amortization, including accretion and write-off of deferred financing costs | **2776** | 2054 |
| &nbsp;&nbsp;&nbsp;Deferred income taxes | **(179)** | (402) |
| &nbsp;&nbsp;&nbsp;Loss (gain) of equity method investee | **231** | (294) |
| &nbsp;&nbsp;&nbsp;(Gain) loss on sale of fixed assets | **(128)** | 4 |
| &nbsp;&nbsp;&nbsp;Share-based compensation expense | **3570** | 1136 |
| &nbsp;&nbsp;&nbsp;Excess tax deficiency related to share-based compensation expense | **183** | 440 |
| &nbsp;&nbsp;&nbsp;Loss on disposal of business, net | **9817** |  |
| &nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | **(49469)** | (14610) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories, net | **(5413)** | 5263 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other assets | **2070** | (1379) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | **41966** | 10792 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other liabilities | **4238** | 9661 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash (used for) provided by operating activities - continuing operations | **(11499)** | 10089 |
| **INVESTING ACTIVITIES:** |  |  |
| Capital expenditures, including intangibles | **(836)** | (6070) |
| Proceeds from sale of fixed assets | **229** | 82 |
| Proceeds from disposal of business, net | **59000** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used for) investing activities - continuing operations | **58393** | (5988) |
| **FINANCING ACTIVITIES:** |  |  |
| Revolving credit facility borrowings | **20000** |  |
| Revolving credit facility payments | **(44000)** |  |
| Proceeds from issuance of debt | **2402** | 6699 |
| Repayments of debt | **(2416)** | (6699) |
| Other financing costs | **(1465)** | (561) |
| Repurchase of Common Shares to satisfy employee tax withholding | **(7)** | (226) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash used for financing activities - continuing operations | **(25486)** | (787) |
| **CASH FLOWS FROM DISCONTINUED OPERATIONS** |  |  |
| Cash provided by operations - discontinued operations | **(3195)** | 1868 |
| Cash used for investing activities - discontinued operations | **(127)** | (1060) |
| Cash used for financing activities - discontinued operations | **0** | 0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net cash (used for) provided by discontinued operations | **(3322)** | 808 |
| Effect of exchange rate changes on cash and cash equivalents | **(607)** | 3155 |
| Net change in cash and cash equivalents | **17479** | 7277 |
| Cash and cash equivalents at beginning of period | **53057** | 71832 |
| Cash and cash equivalents at end of period | $**70536** | $79109 |
| Supplemental disclosure of cash flow information: |  |  |
| &nbsp;&nbsp;Cash paid for interest from continuing operations | $**4378** | $3383 |
| &nbsp;&nbsp;Cash paid for income taxes, net from continuing operations | $**1438** | $1852 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY**

**(Unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **(in thousands)** | **Number of <br>Common <br>Shares<br>outstanding** | **Number of<br> treasury<br>shares** | **Additional<br>paid-in<br>capital** | **Common<br>Shares held <br>in treasury** | **Retained<br>earnings** | **Accumulated<br>other<br>comprehensive<br>loss** | **Total<br>shareholders'<br>equity** |
| BALANCE DECEMBER 31, 2024 | 27695 | 1271 | $225712 | $(38424) | $179985 | $(122013) | $245260 |
| Net loss |  |  |  |  | (7196) |  | (7196) |
| Unrealized gain on derivatives, net |  |  |  |  |  | 1343 | 1343 |
| Currency translation adjustments |  |  |  |  |  | 12783 | 12783 |
| Issuance of Common Shares, net of repurchases | 151 | (151) |  | 5488 |  |  | 5488 |
| Share-based compensation, net |  |  | (4582) |  |  |  | (4582) |
| BALANCE MARCH 31, 2025 | 27846 | 1120 | $221130 | $(32936) | $172789 | $(107887) | $253096 |
| BALANCE DECEMBER 31, 2025 | 28018 | 948 | $219186 | $(27457) | $77150 | $(89100) | $179779 |
| Net loss | **—** | **—** | **—** | **—** | **(27917)** | **—** | **(27917)** |
| Currency translation adjustments | **—** | **—** | **—** | **—** | **—** | **751** | **751** |
| Issuance of Common Shares, net of repurchases | **218** | **(218)** | **—** | **7116** | **—** | **—** | **7116** |
| Share-based compensation, net | **—** | **—** | **(3547)** | **—** | **—** | **—** | **(3547)** |
| BALANCE MARCH 31, 2026 | **28236** | **730** | $**215639** | $**(20341)** | $**49233** | $**(88349)** | $**156182** |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except per share data, unless otherwise stated)**

**(Unaudited)**

**(1) Basis of Presentation**

The accompanying condensed consolidated financial statements have been prepared by Stoneridge, Inc. (the "Company") without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC"). The information furnished in the condensed consolidated financial statements includes normal recurring adjustments and reflects all adjustments, which are, in the opinion of management, necessary for a fair presentation of such financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") have been condensed or omitted pursuant to the SEC's rules and regulations. The results of operations for the three months ended March 31, 2026 are not necessarily indicative of the results to be expected for the full year. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in the Company's 2025 <u>[Form 10-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/1043337/000104333726000023/sri-20251231.htm)</u>.

On January 30, 2026, the Company completed the sale of its Control Devices business segment. The Company determined that the disposal of the Control Devices segment represented a strategic shift that has a major effect on the Company's operations and financial results. Accordingly, the Company has applied the provisions of ASC Topic 205-20, Presentation of Financial Statements — Discontinued Operations, and has retrospectively presented the financial results of the Control Devices segment as discontinued operations in the accompanying condensed consolidated financial statements for all periods presented. The assets and liabilities, results of operations, and cash flows of the Control Devices segment have been segregated from those of continuing operations in the condensed consolidated balance sheets, condensed consolidated statements of comprehensive income (loss), and condensed consolidated statements of cash flows, respectively, for all periods presented. Unless otherwise noted, the disclosures in these notes to the unaudited condensed consolidated financial statements relate solely to the Company's continuing operations. See Note 3 — Discontinued Operations for further information.

Prior to the sale of the Control Devices segment, the Company reported three reportable segments: Electronics, Control Devices, and Stoneridge Brazil. Following the completion of the sale on January 30, 2026, the Control Devices segment is no longer a reportable segment of the Company. The Company now operates in two reportable segments: Electronics and Stoneridge Brazil. In connection with the retrospective presentation of Control Devices as discontinued operations, prior-period segment information has been recast to conform to the current period presentation in accordance with ASC Topic 280, Segment Reporting. See Note 14 — Segment Reporting for further information.

**Reclassifications**

Certain prior period amounts have been reclassified to conform to their 2026 presentation in the condensed consolidated financial statements.

**(2) Recently Issued Accounting Standards**

***Recently Adopted Accounting Standards***

In July 2025, the FASB issued ASU 2025-05, "Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets," which allows entities to use a simplified approach when estimating credit losses for current accounts receivable and contract assets arising from revenue transactions. The standard update permits consideration of collections after the balance sheet date when estimating expected credit losses, and allows consideration of subsequent collections when estimating credit losses, reducing documentation burden. The standard is effective for annual and interim periods within annual reporting periods beginning after December 15, 2025. The Company adopted ASU 2025-05 in the first quarter of 2026. The adoption of this guidance did not have a significant impact on the Company's financial statements.

***Accounting Standards Not Yet Adopted***

In November 2024, the FASB issued ASU 2024-03, "Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures," which requires companies to disclose certain costs and expenses within the notes to the financial statements. The standard is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. We are currently evaluating the impact on our annual consolidated financial statement disclosures.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except per share data, unless otherwise stated)**

**(Unaudited)**

In September 2025, the FASB issued ASU 2025-06, "Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software," which modernizes guidance on internal-use software costs to reflect current development practices and improve operability. The standard eliminates the project stages model and replaces it with a principles based recognition threshold. The standard also creates new capitalization criteria that clarifies capitalization when funding is authorized by management and is probable to be completed and used. The standard is effective for annual and interim periods within annual reporting periods beginning after December 15, 2027. We are currently evaluating the impact on our annual consolidated financial statements and disclosures.

In November 2025, the FASB issued ASU 2025-09, "Derivatives and Hedging (Topic 815): Hedge Accounting Improvements," to better align hedge accounting with an entity's risk management activities and to address issues arising from reference rate reform. The update provides greater flexibility in designating hedging relationships and reduces the risk of hedge dedesignation due to minor changes in hedged items. The new guidance will be applied prospectively and is effective for fiscal years beginning after December 15, 2026, and interim periods within those annual reporting periods, with the option to apply retrospectively. Early adoption is permitted. We are currently evaluating the impact on our annual consolidated financial statements and disclosures.

In December 2025, the FASB issued ASU 2025-10, "Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities," which provides explicit guidance on the accounting for government grants received by business entities. The new guidance will be applied prospectively and is effective for fiscal years beginning after December 15, 2028, and interim periods within those annual reporting periods, with the option to apply retrospectively. Early adoption is permitted. We are currently evaluating the impact on our annual consolidated financial statements and disclosures.

In December 2025, the FASB issued ASU 2025-11, "Interim Reporting (Topic 270): Narrow-Scope Improvements," which provides clarifications intended to improve the consistency and usability of interim disclosure requirements and the applicability to Topic 270. The amendments also provide additional guidance for reporting material events occurring after the most recent annual period. The new guidance will be applied prospectively and is effective for fiscal years beginning after December 15, 2027, and interim periods within those annual reporting periods, with the option to apply retrospectively. Early adoption is permitted. We are currently evaluating the impact on our annual consolidated financial statements and disclosures.

In December 2025, the FASB issued ASU 2025-12, "Codification Improvements," which addresses changes to the Codification that clarify, correct and improve the Codification making it easier to understand and apply. The new guidance will be applied prospectively and is effective for fiscal years beginning after December 15, 2026, and interim periods within those annual reporting periods, with the option to apply retrospectively. Early adoption is permitted. We are currently evaluating the impact on our annual consolidated financial statements and disclosures.

**(3) Discontinued Operations**

***Sale of Control Devices***

On January 30, 2026 (the "Closing Date", "Closing"), the Company and certain of its subsidiaries entered into a Stock Purchase Agreement ("Purchase Agreement") with Control Devices Acquisition, LLC, a Delaware limited liability company, an affiliate of Center Rock Capital Partners, L.P. ("Buyer"), pursuant to which the Company sold, on the Closing Date, its Control Devices business segment (the "Business") via the sale of the Company's interests in its former wholly-owned subsidiaries, Stoneridge Control Devices, Inc. ("Control Devices"), Stoneridge Asia Holdings Ltd., Stoneridge Asia Pacific Electronics (Suzhou) Co. Ltd. ("Stoneridge Suzhou" and such sale, the "Sale").

The purchase price paid to the Company was $59,000 and was subject to customary post-closing adjustments. The Company incurred a loss on disposal, net of tax, of $9,817. The loss on disposal excludes the impact of the $21,628 impairment of fixed assets charge recognized in the fourth quarter of 2025.

The strategic review of the Control Devices business did not meet the criteria for classifying the Control Devices segment as held for sale as of December 31, 2025.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except per share data, unless otherwise stated)**

**(Unaudited)**

*Mexico Manufacturing Agreement*

Simultaneously with the Closing, Stoneridge Electronics and Buyer entered into a Mexico Manufacturing Agreement pursuant to which Stoneridge Electronics will continue manufacturing certain products for Buyer through its Mexico-based maquiladora using machinery and tools transferred to Buyer under the Purchase Agreement. The Mexico Manufacturing Agreement has an initial three-year term and automatically renews for successive one-year periods unless either Stoneridge Electronics or Buyer provides written notice of non-renewal at least twelve months prior to the expiration of the then-current term. Under the Mexico Manufacturing Agreement, Buyer is responsible for payment of materials costs, the product price and certain other costs incurred outside the ordinary course of manufacturing and fulfillment. Product pricing under this agreement was intended to, and is expected to result in, returns that are materially consistent with historical actuals.

During the three months ended March 31, 2026, the Company received payments from Buyer of $3,801 related to manufacturing activities, $8,960 related to materials cost reimbursements, and $6,375 related to the settlement of outstanding accounts payable as of the closing date of the sale.

As of March 31, 2026, amounts receivable from Buyer under the Agreement were $8,928 and amounts payable to Buyer were $500, each presented on a gross basis within accounts receivable and accrued liabilities, respectively, on the Company's consolidated balance sheet.

*China Manufacturing Agreement*

Simultaneously with the Closing, Buyer and Stoneridge Electronics AS entered into a China Manufacturing Agreement pursuant to which Buyer will continue manufacturing certain products for the Company's Electronics business segment at the facility in Suzhou, China transferred to Control Devices under the Purchase Agreement. The China Manufacturing Agreement has an initial twelve (12) month term and will automatically extend for an additional six months unless Stoneridge Electronics AS provides written notice of termination at least thirty (30) days prior to the end of the initial term. Manufacturing costs under the China Manufacturing Agreement are expected to be based on Buyer's actual costs, consistent with the historical cost structure used at the facility in Suzhou, China. Under the China Manufacturing Agreement Stoneridge Electronics AS is responsible for payment of materials costs, shipping costs, manufacturing costs and any excluded costs approved by Stoneridge Electronics AS in writing. A fixed USD/RMB exchange rate applies for the first six (6) months following the Closing, with adjustments every three (3) months thereafter.

During the three months ended March 31, 2026, the Company incurred costs related to the China Manufacturing Agreement of $551 related to manufacturing service fees and $2,068 related to materials cost reimbursement.

As of March 31, 2026, amounts receivable from Buyer under the Agreement were $2,822 and amounts payable to Buyer were $5,715, each presented on a gross basis within accounts receivable and accrued liabilities, respectively, on the Company's consolidated balance sheet.

As a result of the sale and entering into the Mexico and China Manufacturing agreements, the Company does not have any revenues or expenses presented in continuing operations after the disposal transaction that before the disposal transaction were eliminated in consolidated financial statements as intra-entity transactions.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except per share data, unless otherwise stated)**

**(Unaudited)**

The following tables display summarized activity in our condensed consolidated statements of operations for discontinued operations during the three months ended March 31, 2026 and 2025, related to the Control Devices business.

---

| | | |
|:---|:---|:---|
| | **Three months ended March 31,** | **Three months ended March 31,** |
| | **2026 (A)** | 2025 |
| Net sales | $**21960** | $69855 |
| Costs and expenses: |  |  |
| &nbsp;&nbsp;Cost of goods sold | **17749** | 58807 |
| &nbsp;&nbsp;Selling, general and administrative | **5788** | 5831 |
| &nbsp;&nbsp;Design and development | **1210** | 4136 |
| Operating income from discontinued operations | **(2787)** | 1081 |
| &nbsp;&nbsp;Interest expense (income), net | **—** | (75) |
| &nbsp;&nbsp;Other expense, net | **257** | 359 |
| (Loss) income before income taxes from discontinued operations | **(3044)** | 797 |
| Provision (benefit) for income taxes from discontinued operations | **278** | (11) |
| (Loss) income from discontinued operations, net of tax | **(3322)** | 808 |
| Loss on disposal <sup>(B)</sup> | **(8957)** | **—** |
| Income tax provision on loss on disposal | **(860)** | **—** |
| Loss on disposal, net of tax | **(9817)** | **—** |
| (Loss) income from discontinued operations | $**(13139)** | $808 |

---

(A)&nbsp;&nbsp;&nbsp;&nbsp;The operations of the Control Devices business were included only for the period ended January 30, 2026 as the sale was completed on January 30, 2026. Also includes expenses incurred in February and March 2026, after the sale, but related to discontinued operations.

(B)&nbsp;&nbsp;&nbsp;&nbsp;Included in earnings of discontinued operations before income tax expenses for the three months ended March 31, 2026 were transaction costs of $3,700 and $300, respectively.

The following table presents depreciation and amortization and capital expenditures attributable to the Control Devices business for the three months ended March 31, 2026 and 2025:

---

| | | |
|:---|:---|:---|
| | **Three months ended March 31,** | **Three months ended March 31,** |
| | **2026** | **2025** |
| Depreciation and amortization | $**701** | $2326 |
| Capital expenditures | $**127** | $1063 |

---

Intercompany sales to Control Devices were $418 and $5,694 for the three months ended March 31, 2026 and 2025, respectively.

Intercompany purchases from Control Devices were $378 and $1,022 for the three months ended March 31, 2026 and 2025, respectively.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except per share data, unless otherwise stated)**

**(Unaudited)**

The following table summarizes the major classes of assets and liabilities of the Control Devices business presented as discontinued operations as of December 31, 2025:

---

| | |
|:---|:---|
| | **December 31, 2025** |
| **ASSETS** | |
| Current assets: |  |
| &nbsp;&nbsp;Cash and cash equivalents | $13194 |
| &nbsp;&nbsp;Accounts receivable, less reserves  | 42410 |
| &nbsp;&nbsp;Inventories, net | 26180 |
| &nbsp;&nbsp;Prepaid expenses and other current assets | 4558 |
| Long-term assets: |  |
| &nbsp;&nbsp;Property, plant and equipment, net | 16263 |
| &nbsp;&nbsp;Intangible assets, net | 341 |
| &nbsp;&nbsp;Other assets | 3098 |
| Total assets of discontinued operations | $106044 |
| **LIABILITIES** |  |
| &nbsp;&nbsp;Accounts payable | $19769 |
| &nbsp;&nbsp;Accrued expenses and other current liabilities | 10186 |
| &nbsp;&nbsp;Long-term liabilities | 4733 |
| Total liabilities of discontinued operations | $34688 |

---

**(4) Revenue**

Revenue is recognized when obligations under the terms of a contract with our customer are satisfied; generally this occurs with the transfer of control of our products and services, which is usually when the parts are shipped or delivered to the customer's premises. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. The transaction price will include estimates of variable consideration to the extent it is probable that a significant reversal of revenue recognized will not occur. Incidental items that are not significant in the context of the contract are recognized as expense. The expected costs associated with our base warranties continue to be recognized as expense when the products are sold. Customer returns only occur if products do not meet the specifications of the contract and are not connected to any repurchase obligations of the Company.

The Company does not have any financing components or significant payment terms as payment occurs shortly after the point of sale. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction that are collected by the Company from a customer are excluded from revenue. Amounts billed to customers related to shipping and handling costs are included in net sales in the condensed consolidated statements of operations. Shipping and handling costs associated with outbound freight after control over a product is transferred to the customer are accounted for as a fulfillment cost and are included in cost of sales.

***Revenue by Reportable Segment***

*Electronics.* Our Electronics segment designs and manufactures advanced driver information solutions, vision systems, connectivity and compliance solutions and control modules. These products are sold principally to the commercial and off-highway vehicle markets primarily through our OEM and aftermarket channels in the European, North American and Asia Pacific regions. Our vision and safety systems are sold principally to the commercial vehicle and off-highway vehicle markets in the European and North American regions.

*Stoneridge Brazil.* Our Stoneridge Brazil segment primarily serves the South American region and specializes in the design, manufacture and sale of vehicle tracking devices and monitoring services, driver information systems, vehicle security alarms and convenience accessories, telematics solutions and multimedia devices. Stoneridge Brazil sells its products through the aftermarket distribution channel, to factory authorized dealer installers, also referred to as original equipment services and directly to OEMs. In addition, monitoring services and tracking devices are sold directly to corporate customers and individual consumers.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except per share data, unless otherwise stated)**

**(Unaudited)**

The following tables disaggregate our revenue by reportable segment and geographical location<sup>(1)</sup> for the three months ended March 31, 2026 and 2025:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Electronics** | **Electronics** | **Stoneridge Brazil** | **Stoneridge Brazil** | **Consolidated** | **Consolidated** |
| **Three months ended March 31,** | **2026** | **2025** | **2026** | **2025** | **2026** | **2025** |
| Net Sales: |  |  |  |  |  |  |
| &nbsp;&nbsp;North America | $**46893** | $42769 | $**—** | $— | $**46893** | $42769 |
| &nbsp;&nbsp;South America | **—** |  | **15999** | 14274 | **15999** | 14274 |
| &nbsp;&nbsp;Europe | **97576** | 91043 | **—** |  | **97576** | 91043 |
| &nbsp;&nbsp;Asia Pacific | **379** | 971 | **—** |  | **379** | 971 |
| &nbsp;&nbsp;&nbsp;Total net sales | $**144848** | $134783 | $**15999** | $14274 | $**160847** | $149057 |

---

______________________

(1)Company sales based on geographic location are where the sale originates not where the customer is located.

***Performance Obligations***

For OEM and Tier 1 supplier customers, the Company typically enters into contracts to provide serial production parts that consist of a set of documents including, but not limited to, an award letter, master purchase agreement and master terms and conditions. For each production product, the Company enters into separate purchase orders that contain the product specifications and an agreed-upon price. The performance obligation does not exist until a customer release is received for a specific number of parts. The majority of the parts sold to OEM and Tier 1 supplier customers are customized to the specific customer, with the exception of camera monitoring systems ("CMS") sold through our aftermarket channel that are mostly common across all customers. The transaction price is equal to the contracted price per part and there is no expectation of material variable consideration in the transaction price. For most customer contracts, the Company does not have an enforceable right to payment at any time prior to when the parts are shipped or delivered to the customer; therefore, the Company recognizes revenue at the point in time it satisfies a performance obligation by transferring control of a part to the customer. Certain customer contracts contain an enforceable right to payment if the customer terminates the contract for convenience and therefore are recognized over time using the cost to complete input method.

Our aftermarket products, including accessories and replacement parts, are focused on meeting the demand for safety, compliance and entertainment applications and are sold primarily to aftermarket distributors in our South American and European markets, as well as direct to aftermarket customers in North America. Aftermarket products have one type of performance obligation, which is the delivery of aftermarket parts and spare parts. For aftermarket customers, the Company typically has standard terms and conditions for all customers. In addition, aftermarket products have alternative use as they can be sold to multiple customers. Revenue for aftermarket part production contracts is recognized at a point in time when the control of the parts transfers to the customer, which is based on the shipping terms. Aftermarket contracts may include variable consideration related to discounts and rebates, which is included in the transaction price upon recognizing the product revenue.

A small portion of the Company's sales are comprised of monitoring services that include both monitoring devices and fees to individual, corporate, fleet and cargo customers in our Stoneridge Brazil segment. These monitoring service contracts are generally not capable of being distinct and are accounted for as a single performance obligation. We recognize revenue for our monitoring products and services contracts over the life of the contract. There is no variable consideration associated with these contracts. The Company has the right to consideration from a customer in the amount that corresponds directly with the value to the customer of the Company's performance to date. Therefore, the Company recognizes revenue over time using the practical expedient ASC 606-10-55-18 in the amount the Company has a "right to invoice" rather than selecting an output or input method.

***Contract Balances***

The Company had no material contract assets, contract liabilities or capitalized contract acquisition costs as of March 31, 2026 and December 31, 2025.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except per share data, unless otherwise stated)**

**(Unaudited)**

**(5) Inventories**

Inventories are valued at the lower of cost (using either the first-in, first-out ("FIFO") or average cost methods) or net realizable value. The Company evaluates and adjusts as necessary its excess and obsolescence reserve on a quarterly basis. Excess inventories are quantities of items that exceed anticipated sales or usage for a reasonable period. The Company has guidelines for calculating provisions for excess inventories based on the number of months of inventories on hand compared to anticipated sales or usage. Management uses its judgment to forecast sales or usage and to determine what constitutes a reasonable period. Inventory cost includes material, labor and overhead. Inventories consist of the following:

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| Raw materials | $**78943** | $78256 |
| Work-in-progress | **6209** | 5610 |
| Finished goods | **26100** | 22556 |
| &nbsp;&nbsp;Total inventories, net | $**111252** | $106422 |

---

Inventory valued using the FIFO method was $95,290 and $91,848 at March 31, 2026 and December 31, 2025, respectively. Inventory valued using the average cost method was $15,962 and $14,574 at March 31, 2026 and December 31, 2025, respectively.

**(6) Financial Instruments and Fair Value Measurements**

**Financial Instruments**

A financial instrument is cash or a contract that imposes an obligation to deliver or conveys a right to receive cash or another financial instrument. The carrying values of cash and cash equivalents, accounts receivable and accounts payable are considered to be representative of fair value because of the short maturity of these instruments. The fair value of debt approximates the carrying value of debt, due to the variable interest rate on our Credit Facility and the maturity of outstanding debt.

**Derivative Instruments and Hedging Activities**

During 2025, the Company had open Mexican peso-denominated foreign currency forward contracts. The Company used foreign currency forward contracts solely for hedging and not for speculative purposes. Management believes that its use of these instruments to reduce risk was in the Company's best interest. The counterparties to these financial instruments were financial institutions with investment grade credit ratings.

**Foreign Currency Exchange Rate Risk**

Foreign currency transactions are remeasured into the functional currency using translation rates in effect at the time of the transaction with the resulting adjustments included on the condensed consolidated statements of operations within other expense (income), net. These foreign currency transaction losses (gains), including the impact of hedging activities, were $275 and $(258) for the three months ended March 31, 2026 and 2025, respectively.

The Company conducts business internationally and, therefore, is exposed to foreign currency exchange rate risk. The Company uses derivative financial instruments as cash flow hedges to manage its exposure to fluctuations in foreign currency exchange rates by reducing the effect of such fluctuations on foreign currency denominated intercompany transactions, inventory purchases and other foreign currency exposures.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except per share data, unless otherwise stated)**

**(Unaudited)**

**Cash Flow Hedges**

The Company entered into foreign currency forward contracts to hedge the Mexican peso currency in 2025. These forward contracts were executed to hedge forecasted transactions and have been accounted for as cash flow hedges. As such, gains and losses on derivatives qualifying as cash flow hedges are recorded in accumulated other comprehensive loss, to the extent that hedges are effective, until the underlying transactions are recognized in earnings. Unrealized amounts in accumulated other comprehensive loss fluctuate based on changes in the fair value of hedge derivative contracts at each reporting period. The cash flow hedges were highly effective. The effectiveness of the transactions were measured using regression analysis and forecasted future purchases of the currency.

In certain instances, the foreign currency forward contracts may not qualify for hedge accounting or are not designated as hedges and, therefore, are marked-to-market with gains and losses recognized in the Company's condensed consolidated statements of operations as a component of other expense (income), net.

The Company's foreign currency forward contracts offset a portion of the gains and losses on the underlying foreign currency denominated transactions as follows:

*Mexican peso-denominated Foreign Currency Forward Contracts – Cash Flow Hedges*

The Company held Mexican peso-denominated foreign currency forward contracts which expired ratably on a monthly basis from January 2025 to December 2025.

The Company evaluated the effectiveness of the Mexican peso denominated forward contracts held during 2025 and concluded that the hedges were highly effective.

Gross amounts recorded for the cash flow hedges in other comprehensive income and in net loss for the three months ended March 31 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Gain recorded in other<br>comprehensive income** | **Gain recorded in other<br>comprehensive income** | **(Loss) reclassified from**<br>**other comprehensive income into net loss** <sup>(A)</sup> | **(Loss) reclassified from**<br>**other comprehensive income into net loss** <sup>(A)</sup> |
| | **2026** | **2025** | **2026** | **2025** |
| Derivatives designated as cash flow hedges: |  |  |  |  |
| &nbsp;&nbsp;Forward currency contracts | $**—** | $1103 | $**—** | $(597) |

---

_____________________________

(A) Losses reclassified from other comprehensive income into net loss recognized in cost of goods sold ("COGS") in the Company's condensed consolidated statements of operations were $(597) for the three months ended March 31, 2025.

Cash flows from derivatives used to manage foreign currency exchange risks are classified as operating activities within the condensed consolidated statements of cash flows.

**Fair Value Measurements**

Historically, certain assets and liabilities held by the Company were measured at fair value on a recurring basis and were categorized using the three levels of the fair value hierarchy based on the reliability of the inputs used. Fair values estimated using Level 1 inputs consisted of quoted prices in active markets for identical assets or liabilities that the Company had the ability to access at the measurement date. Fair values estimated using Level 2 inputs, other than quoted prices, were observable for the asset or liability, either directly or indirectly and included among other things, quoted prices for similar assets or liabilities in markets that were active or inactive as well as inputs other than quoted prices that were observable. For forward currency contracts, inputs included forward foreign currency exchange rates. Fair values estimated using Level 3 inputs consisted of significant unobservable inputs. There were no assets or liabilities measured at fair value at March 31, 2026 or December 31, 2025.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except per share data, unless otherwise stated)**

**(Unaudited)**

**(7) Share-Based Compensation**

Compensation expense for share-based compensation arrangements, which is recognized in the condensed consolidated statements of operations as a component of SG&A expense, was $3,570 and $1,136 for the three months ended March 31, 2026 and 2025, respectively. The three months ended March 31, 2026 includes accelerated expense for employee retirements.

**(8) Debt**

Debt consisted of the following at March 31, 2026 and December 31, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** | **Interest rate at March 31, 2026** | **Maturity** |
| **Revolving Credit Facility** | | | | |
| &nbsp;&nbsp;Revolving Credit Facility | $**156470** | $180942 | **7.53%** | **July 2027** |

---

***Revolving Credit Facility***

On November 2, 2023, the Company entered into the Fifth Amended and Restated Credit Agreement (the "Credit Facility"). The Credit Facility provided for a $275,000 senior secured revolving credit facility and it replaced and superseded the Fourth Amended and Restated Credit Agreement. The Credit Facility had an accordion feature, which allows the Company to increase the availability by up to $150,000 upon the satisfaction of certain conditions, including the consent of lenders providing the increase in commitments, and also included a letter of credit subfacility, swing line subfacility and multicurrency subfacility. The Credit Facility had a termination date of November 2, 2026. Borrowings under the Credit Facility bear interest at either the Base Rate or the SOFR rate, at the Company's option, plus the applicable margin as set forth in the Credit Facility. The Credit Facility contains certain financial covenants that require the Company to maintain less than a maximum leverage ratio and more than a minimum interest coverage ratio.

The Credit Facility contains customary affirmative covenants and representations. The Credit Facility also contains customary negative covenants, which, among other things, are subject to certain exceptions, including restrictions on (i) indebtedness, (ii) liens, (iii) liquidations, mergers, consolidations and acquisitions, (iv) disposition of assets or subsidiaries, (v) affiliate transactions, (vi) continuation of or change in business, (vii) restricted payments, (viii) restrictions in agreements on dividends, intercompany loans and granting liens on the collateral, (ix) loans and investments and (x) changes in organizational documents and fiscal year. The Credit Facility contains customary events of default, subject to customary thresholds and exceptions, including, among other things, (i) non-payment of principal and non-payment of interest and fees, (ii) a material inaccuracy of a representation or warranty at the time made, (iii) a failure to comply with any covenant, subject to customary grace periods in the case of certain affirmative covenants, (iv) cross default of other debt, final judgments and other adverse orders in excess of $30,000, (v) any loan document shall cease to be a legal, valid and binding agreement, (vi) certain uninsured losses or proceedings against assets with a value in excess of $30,000, (vii) ERISA events, (viii) a change of control, or (ix) bankruptcy or insolvency proceedings.

On February 26, 2025, the Company entered into Amendment No. 1 to the Fifth Amended and Restated Credit Agreement and Waiver ("Amendment No. 1"). Amendment No. 1 provided for certain covenant relief and restrictions during the "Covenant Relief Period" (the period ending on the date that the Company was required to deliver a compliance certificate for the quarter ending December 31, 2025). During the Covenant Relief Period:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the maximum leverage ratio of 3.50 was increased to 6.00 for the quarter ended March 31, 2025, 5.50 for the quarter ended June 30, 2025, 4.50 for the quarter ended September 30, 2025 and 3.50 for the quarter ended December 31, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the minimum interest coverage ratio of 3.50 was waived for the quarter ended December 31, 2024 and was reduced to 2.00 for the quarters ended March 31 and June 30, 2025, and 2.50 and 3.50 for the quarters ended September 30, 2025 and December 31, 2025, respectively;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Company's aggregate amount of cash and cash equivalents, defined as 100% of North American and 65% of foreign cash balances, could not exceed $70,000;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the sale of significant assets (as defined) required repayment in the amount of any net cash proceeds received resulting in the reduction of the Credit Facility commitment, at the lesser of $100,000 or the net cash proceeds;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• there were certain restrictions on Restricted Payments (as defined); and

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except per share data, unless otherwise stated)**

**(Unaudited)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a Permitted Acquisition (as defined) could not be consummated unless otherwise approved in writing by the required lenders.

Amendment No. 1 added an additional level to the leverage ratio based pricing grid, through maturity, when the leverage ratio is greater than 3.50.

As a result of entering into Amendment No.1, the Company capitalized $561 of deferred financing costs during the three months ended March 31, 2025.

On November 5, 2025, the Company entered into Amendment No. 2 to the Fifth Amended and Restated Credit Agreement and Consent Agreement ("Amendment No. 2"). Amendment No. 2 amended the Credit Facility and provided for certain covenant relief and restrictions through the Credit Facility's termination date of November 2, 2026. Amendment No. 2 superseded certain terms of the Credit Facility and Amendment No. 1 beginning November 5, 2025 and ending at the Credit Facility's termination date of November 2, 2026. Amendment No. 2 amended certain Credit Facility terms and provided covenant relief as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• borrowing capacity was reduced from $275,000 to $225,000;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the sale of the Control Devices business (as defined) was a permitted transaction and upon notice would result in the reduction of the Credit Facility commitment, at the lesser of $50,000 or the net cash proceeds of this transaction;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the current minimum interest coverage ratio of 2.5 was extended through the quarter ending March 31, 2026 and increased to 3.5 for the quarter ended June 30, 2026 and thereafter;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ if the Control Devices business sale is consummated, the minimum interest coverage ratio will increase to 3.5 as of the last day of the first full quarter ending after the sale and thereafter; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the maximum leverage ratio of 4.5 for the quarter ended September 30, 2025 and 3.5 for the quarter ended December 31, 2025 and thereafter remained unchanged.

As a result of entering into Amendment No.2, the Company capitalized $216 of deferred financing costs and wrote off $192 of previously recorded deferred financing costs during the year ended December 31, 2025.

On January 30, 2026, as a result of the sale of the Control Devices business, the Credit Facility borrowing capacity was reduced from $225,000 to $175,000.

On March 6, 2026, the Company entered into Amendment No. 3 to the Fifth Amended and Restated Credit Agreement ("Amendment No. 3"). Amendment No. 3 amends and restates the Credit Facility in its entirety beginning December 31, 2025 and ending at the Credit Facility's amended termination date of July 1, 2027. Amendment No. 3 also provides for certain covenant relief and adjustments to terms and conditions as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• expiration date of the Credit Facility is extended from November 2, 2026 to July 1, 2027;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the current minimum interest coverage ratio of 2.50 was reduced to 1.60 for the quarter ended March 31, 2026, 1.70 for the quarter ended June 30, 2026, 1.75 for the quarter ended September 30, 2026 and 2.50 for the quarter ended December 31, 2026 and thereafter;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the maximum leverage ratio was increased to 3.75 for the quarter ended December 31, 2025, increases to 6.25 for the quarter ended March 31, 2026, 6.75 for the quarter ended June 30, 2026, 6.00 for the quarter ended September 30, 2026 and 4.00 for the quarter ended December 31, 2026 and thereafter;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• on December 31, 2026, the current borrowing capacity of $175,000 will be reduced to the lesser of $157,500 or the then current Credit Facility commitment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• modifications to Consolidated EBITDA (as defined); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• modifications and additions to affirmative covenants.

As a result of entering into Amendment No.3, the Company capitalized $1,540 of deferred financing costs and wrote off $182 of previously recorded deferred financing costs during the three months ended March 31, 2026.

Borrowings outstanding on the Credit Facility were $156,470 and $180,942 at March 31, 2026 and December 31, 2025, respectively.

The Company was in compliance with all Credit Facility covenants at March 31, 2026 and December 31, 2025.

The Company also has outstanding letters of credit of $3,106 at March 31, 2026 and $2,106 at December 31, 2025.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except per share data, unless otherwise stated)**

**(Unaudited)**

***Debt***

The Company's wholly owned subsidiary located in Stockholm, Sweden (the "Stockholm subsidiary"), has an overdraft credit line that allows overdrafts on the subsidiary's bank account up to a daily maximum level of 20,000 Swedish krona, or $2,115 and $2,174, at March 31, 2026 and December 31, 2025, respectively. At March 31, 2026 and December 31, 2025, there were no borrowings outstanding on this overdraft credit line. During the three months ended March 31, 2026, the subsidiary borrowed and repaid 21,788 Swedish krona, or $2,598. The Stockholm subsidiary has pledged certain of its assets as collateral in order to obtain a guarantee of certain of the Stockholm subsidiary's obligations to third parties.

**(9) Loss Per Share**

Basic loss per share was computed by dividing net loss by the weighted-average number of Common Shares outstanding for each respective period. Diluted loss per share was calculated by dividing net loss by the weighted-average of all potentially dilutive Common Shares that were outstanding during the periods presented. However, for all periods in which the Company recognized a net loss, the Company did not recognize the effect of the potential dilutive securities as their inclusion would be anti-dilutive. Potential dilutive shares of 517,198 and 136,118 for the three months ended March 31, 2026 and 2025, respectively, were excluded from diluted loss per share because the effect would be anti-dilutive.

Weighted-average Common Shares outstanding used in calculating basic and diluted earnings per share were as follows:

---

| | | |
|:---|:---|:---|
| | **Three months ended<br>March 31,** | **Three months ended<br>March 31,** |
| | **2026** | **2025** |
| Basic weighted-average Common Shares outstanding | **27897778** | 27679924 |
| Effect of dilutive shares | **—** |  |
| &nbsp;&nbsp;Diluted weighted-average Common Shares outstanding | **27897778** | 27679924 |

---

There were 734,923 and 1,002,950 performance-based right to receive Common Shares outstanding at March 31, 2026 and 2025, respectively. The right to receive Common Shares are included in the computation of diluted earnings per share, to the extent they are not anti-dilutive, based on the number of Common Shares that would be issuable if the end of the quarter were the end of the performance period.

**(10) Accumulated Other Comprehensive Loss**

Changes in accumulated other comprehensive loss for the three months ended March 31, 2026 and 2025 were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Foreign<br>currency<br>translation** | **Unrealized<br>gain (loss)<br>on derivatives** | **Total** |
| Balance at January 1, 2026 | $**(89100)** | $**—** | $**(89100)** |
| &nbsp;&nbsp;Other comprehensive income before reclassifications | **751** | **—** | **751** |
| &nbsp;&nbsp;Amounts reclassified from accumulated other comprehensive loss | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net other comprehensive income, net of tax | **751** | **—** | **751** |
| Balance at March 31, 2026 | $**(88349)** | $**—** | $**(88349)** |
| Balance at January 1, 2025 | $(120095) | $(1918) | $(122013) |
| &nbsp;&nbsp;Other comprehensive income before reclassifications | 12783 | 871 | 13654 |
| &nbsp;&nbsp;Amounts reclassified from accumulated other comprehensive loss |  | 472 | 472 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net other comprehensive income, net of tax | 12783 | 1343 | 14126 |
| Balance at March 31, 2025 | $(107312) | $(575) | $(107887) |

---

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except per share data, unless otherwise stated)**

**(Unaudited)**

**(11) Commitments and Contingencies**

From time to time, we are subject to various legal actions and claims incidental to our business, including those arising out of breach of contracts, product warranties, product liability, patent infringement, regulatory matters and employment-related matters. The Company establishes accruals for matters which it believes that losses are probable and can be reasonably estimated. Although it is not possible to predict with certainty the outcome of these matters, the Company is of the opinion that the ultimate resolution of these matters will not have a material adverse effect on its consolidated results of operations or financial position.

As a result of environmental studies performed at the Company's former facility located in Sarasota, Florida, the Company became aware of soil and groundwater contamination at the site. The Company engaged an environmental engineering consultant to assess the level of contamination and to develop a remediation and monitoring plan for the site. Soil remediation at the site was completed during the year ended December 31, 2010. A remedial action plan was approved by the Florida Department of Environmental Protection and groundwater remediation began in the fourth quarter of 2015. During the three months ended March 31, 2026 and 2025, the Company did not recognize any expense related to groundwater remediation. At March 31, 2026 and December 31, 2025, the Company had accrued liabilities of $138 and $142, respectively, related to expected future remediation costs. At March 31, 2026 and December 31, 2025, $38 and $42, respectively, were recorded as a component of accrued expenses and other current liabilities in the condensed consolidated balance sheets while the remaining amounts as of March 31, 2026 and December 31, 2025 were recorded as a component of other long-term liabilities. Costs associated with the recorded liability will be incurred to complete the groundwater remediation and monitoring. The recorded liability is based on assumptions in the remedial action plan as well as estimates for future remediation activities. Although the Company sold the Sarasota facility and related property in December 2011, the liability to remediate the site contamination remains the responsibility of the Company. Due to the ongoing site remediation, the Company is currently required to maintain a $1,489 letter of credit for the benefit of the buyer.

The Company's Stoneridge Brazil subsidiary has civil, labor, environmental and other tax contingencies (excluding income tax) for which the likelihood of loss is deemed to be reasonably possible, but not probable, by the Company's legal advisors in Brazil. As a result, no provision has been recorded with respect to these contingencies, which amounted to R$43,792 ($8,391) and R$43,818 ($7,964) at March 31, 2026 and December 31, 2025, respectively. An unfavorable outcome on these contingencies could result in significant cost to the Company and adversely affect its results of operations and cash flows.

On August 12, 2020, the Brazilian Administrative Counsel for Economic Defense ("CADE") issued a ruling against Stoneridge Brazil for abuse of dominance and market foreclosure through its prior use of exclusivity provisions in agreements with its distributors. The CADE tribunal imposed a R$7,995 ($1,532) fine which is included in the reasonably possible contingencies noted above. The Company continues to challenge this ruling in Brazilian federal court to reverse this decision by the CADE tribunal.

**Long-Term Supply Commitment**

In 2022, the Company entered into a long-term supply agreement, as amended, with a supplier for the purchase of certain electronic semiconductor components through December 31, 2030. Pursuant to the agreement, the Company paid capacity deposits of $1,000 each in December 2022 and June 2023. The capacity deposits are recognized in prepaid and other current assets on our condensed consolidated balance sheets and amortized ratably based on purchases over the life of the purchase commitment. This long-term supply agreement requires the Company to purchase minimum annual volumes while requiring the supplier to sell these components at a fixed price. The Company did not purchase any of these components, related to the annual required purchases, during the three months ended March 31, 2026 and 2025, respectively. The Company is required to purchase $3,876, $7,489, $8,861, $5,975 and $2,170 of these components in each of the years 2026 through 2030, respectively. We evaluate our long-term supply agreement on a continuous basis in the context of customer demand and overall market dynamics. Part of that evaluation process has resulted in re-negotiating minimum annual volumes in the past. Should customer demand and market dynamics require us to re-evaluate our long-term supply commitments, we intend to engage with the supplier to negotiate an amendment to the long term supply agreement and amend the supply commitments to align with current market conditions.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except per share data, unless otherwise stated)**

**(Unaudited)**

***Product Warranty and Recall***

Amounts accrued for product warranty and recall claims are established based on the Company's best estimate of the amounts necessary to settle existing and future claims on products sold as of the balance sheet dates. These accruals are based on several factors including past experience, production changes, industry developments and various other considerations. Our estimate is based on historical trends of units sold and claim payment amounts, combined with our current understanding of the status of existing claims, forecasts of the resolution of existing claims, expected future claims on products sold and commercial discussions with our customers. The key factors in our estimate are the warranty period and the customer source. The Company can provide no assurances that it will not experience material claims or that it will not incur significant costs to defend or settle such claims beyond the amounts accrued. The current portion of the product warranty and recall reserve is included as a component of accrued expenses and other current liabilities on the condensed consolidated balance sheets. Product warranty and recall reserve included $8,997 and $9,378 of a long-term liability at March 31, 2026 and December 31, 2025, respectively, which is included as a component of other long-term liabilities on the condensed consolidated balance sheets.

In 2023, the Company received a demand for arbitration from one of our customers seeking recovery of warranty claims related to alleged defects in PM sensor products sold prior to the Company's exit from that product line in 2019. The Company denies responsibility for these claims. Based on our review of the technical and legal merits, we believe these warranty claims lack substantive merit and are significantly overstated. An arbitration hearing was held in the first quarter of 2026 in which the claimant sought approximately $41,000 in direct warranty damages plus additional reputational damage; a resolution is expected by the end of the year. While the Company believes a material loss is not probable, given the inherent uncertainty of arbitration proceedings, it is reasonably possible that the outcome could result in a loss in an amount that the Company is currently unable to estimate.

The following provides a reconciliation of changes in product warranty and recall reserve liability:

---

| | | |
|:---|:---|:---|
| **Three months ended March 31,** | **2026** | **2025** |
| Product warranty and recall reserve at beginning of period | $**22302** | $23373 |
| &nbsp;&nbsp;Accruals for warranties established during period | **3056** | 3641 |
| &nbsp;&nbsp;Aggregate changes in pre-existing liabilities due to claim developments | **401** | 681 |
| &nbsp;&nbsp;Settlements made during the period | **(4226)** | (3616) |
| &nbsp;&nbsp;Foreign currency translation | **(375)** | 1729 |
| Product warranty and recall reserve at end of period | $**21158** | $25808 |

---

**(12) Business Realignment**

The Company regularly evaluates the performance of its businesses and cost structures, including personnel, and makes necessary changes thereto in order to optimize its results. The Company also evaluates the required skill sets of its personnel and periodically makes strategic changes. As a consequence of these actions, the Company incurs severance related costs that are referred to as business realignment charges.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except per share data, unless otherwise stated)**

**(Unaudited)**

Business realignment charges incurred by reportable segment were as follows:

---

| | | |
|:---|:---|:---|
| | **Three months ended<br>March 31,** | **Three months ended<br>March 31,** |
| | **2026** | **2025** |
| Electronics <sup>(A)</sup> | **384** | 1373 |
| Unallocated Corporate <sup>(B)</sup> | **—** | 1077 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total business realignment charges | $**384** | $2450 |

---

_____________________________________

(A) Severance costs for the three months ended March 31, 2026 related to SG&A were $384, and related to severance costs in Europe. Severance costs for the three months ended March 31, 2025 related to COGS, SG&A and D&D were $1,073, $106 and $194, respectively. The majority of the 2025 business realignment costs relate to operational efficiency initiatives at our Juarez facility.

(B) Severance related costs for the three months ended March 31, 2025 related to SG&A were $1,077.

Business realignment charges incurred, classified by statement of operations line item were as follows:

---

| | | |
|:---|:---|:---|
| | **Three months ended<br>March 31,** | **Three months ended<br>March 31,** |
| | **2026** | **2025** |
| Cost of goods sold | $**—** | $1073 |
| Selling, general and administrative | **384** | 1183 |
| Design and development | **—** | 194 |
| &nbsp;&nbsp;Total business realignment charges | $**384** | $2450 |

---

Reconciliations of the beginning and ending liability balances related to business realignment were as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | | **Utilization** | **Utilization** | |
| |<br>**Accrual as of January 1, 2026** |<br>**2026 Charge to Expense** | **Cash** | **Non-Cash** |<br>**Accrual as of <br>March 31, 2026** |
| Employee termination costs | $**568** | $**384** | $**(353)** | $**—** | $**599** |
| &nbsp;&nbsp;Total | $**568** | $**384** | $**(353)** | $**—** | $**599** |
|  |  |  | **Utilization** | **Utilization** |  |
|  | **Accrual as of January 1, 2026** | **2025 Charge to Expense** | **Cash** | **Non-Cash** | **Accrual as of <br>March 31, 2025** |
| Employee termination costs | $411 | $2450 | $(878) | $— | $1983 |
| &nbsp;&nbsp;Total | $411 | $2450 | $(878) | $— | $1983 |

---

**(13) Income Taxes**

For interim tax reporting, we estimate our annual effective tax rate and apply it to our year to date ordinary income. Tax jurisdictions with a projected or year to date loss for which a benefit cannot be realized are excluded.

For the three months ended March 31, 2026, income tax expense from continuing operations of $1,414 was attributable to the mix of earnings among tax jurisdictions, tax credits and incentives and the impact of valuation allowances in certain jurisdictions. The effective tax rate of (10.6)% varies from the statutory rate primarily due to tax credits and incentives and the impact of valuation allowances in certain jurisdictions.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except per share data, unless otherwise stated)**

**(Unaudited)**

For the three months ended March 31, 2025, income tax expense from continuing operations of $1,575 was attributable to the mix of earnings among tax jurisdictions, the impact of valuation allowances in certain jurisdictions and tax credits and incentives offset by U.S. taxes on foreign earnings. The effective tax rate of (24.5)% varies from the statutory rate primarily due to the impact of valuation allowances in certain jurisdictions and tax credits and incentives offset by U.S. taxes on foreign earnings.

**(14) Segment Reporting**

Operating segments are defined as components of an enterprise that are evaluated regularly by the Company's chief operating decision maker ("CODM") in deciding how to allocate resources and in assessing performance. The Company's CODM is the Chief Executive Officer.

The Company has two reportable segments, Electronics and Stoneridge Brazil, which also represent its operating segments. The Electronics reportable segment produces advanced driver information solutions, vision systems, connectivity and compliance solutions and control modules. The Stoneridge Brazil reportable segment designs and manufactures vehicle tracking devices and monitoring services, driver information systems, vehicle security alarms and convenience accessories telematics solutions and multimedia devices.

In January 2026, the Company completed the sale of its Control Devices segment. Control Devices was previously a separate reportable segment of the Company; however, it is not reflected in the segment information presented below for any period shown.

The accounting policies of the Company's reportable segments are the same as those described in Note 2, "Summary of Significant Accounting Policies" of the Company's 2025 <u>[Form 10-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/1043337/000104333726000023/sri-20251231.htm)</u>. The Company's management evaluates the performance of its reportable segments based primarily on revenues from external customers, operating income and capital expenditures. Inter-segment sales are accounted for on terms similar to those to third parties and are eliminated upon consolidation.

The Company's management, including the CODM, utilizes operating income as the key performance measure of segment profitability to evaluate segment performance, and for planning and forecasting purposes to allocate resources to the segments, as management believes this measure is most reflective of the financial performance of the Company's operating segments. The CODM regularly evaluates budget-to-actual and period-over-period variances for this metric when making decisions about the allocation of operating and capital resources to each segment. The CODM also uses operating income in evaluating the operating performance of each segment and as part of determining the compensation of the segment managers and certain other employees. COGS and D&D are the significant expenses regularly reviewed by the CODM. Other segment costs primarily include SG&A items.

The financial information presented below is for our two reportable operating segments and includes adjustments for unallocated corporate costs and intercompany eliminations, where applicable. Such costs and eliminations do not meet the requirements for being classified as an operating segment. Unallocated Corporate costs include various support functions, such as accounting/finance, executive administration, human resources, information technology and legal as well as share-based compensation.

A summary of financial information by reportable segment is as follows:

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except per share data, unless otherwise stated)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **Three months ended<br>March 31,** | **Three months ended<br>March 31,** |
| | **2026** | **2025** |
| Net Sales: |  |  |
| &nbsp;&nbsp;&nbsp;Electronics | $**144848** | $134783 |
| &nbsp;&nbsp;&nbsp;Inter-segment sales | **13** | 5751 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Electronics net sales | **144861** | 140534 |
| &nbsp;&nbsp;&nbsp;Stoneridge Brazil | **15999** | 14274 |
| &nbsp;&nbsp;&nbsp;Inter-segment sales | **2143** | 135 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stoneridge Brazil net sales | **18142** | 14409 |
| &nbsp;&nbsp;&nbsp;Eliminations | **(2156)** | (5886) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total net sales | $**160847** | $149057 |
| Cost of Goods Sold: |  |  |
| &nbsp;&nbsp;Electronics | $**116822** | $104526 |
| &nbsp;&nbsp;Stoneridge Brazil | **9173** | 9169 |
| &nbsp;&nbsp;Unallocated Corporate <sup>(A)</sup> | **(104)** | 112 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cost of goods sold | $**125891** | $113807 |
| Design and Development: |  |  |
| &nbsp;&nbsp;Electronics | $**10979** | $12000 |
| &nbsp;&nbsp;Stoneridge Brazil | **426** | 782 |
| &nbsp;&nbsp;Unallocated Corporate <sup>(A)</sup> | **—** | 909 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total design and development | $**11405** | $13691 |
| Other Segment Costs: |  |  |
| &nbsp;&nbsp;Electronics | $**13314** | $12751 |
| &nbsp;&nbsp;Stoneridge Brazil | **5079** | 3738 |
| &nbsp;&nbsp;Unallocated Corporate <sup>(A)</sup> | **14136** | 9376 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other segment costs | $**32529** | $25865 |
| Operating (Loss) Income: |  |  |
| &nbsp;&nbsp;&nbsp;Electronics | $**3732** | $5505 |
| &nbsp;&nbsp;&nbsp;Stoneridge Brazil | **1321** | 585 |
| &nbsp;&nbsp;&nbsp;Unallocated Corporate <sup>(A)</sup> | **(14031)** | (10396) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating loss | $**(8978)** | $(4306) |
| Depreciation and Amortization: |  |  |
| &nbsp;&nbsp;&nbsp;Electronics | $**4094** | $3540 |
| &nbsp;&nbsp;&nbsp;Stoneridge Brazil | **1262** | 1093 |
| &nbsp;&nbsp;&nbsp;Unallocated Corporate | **343** | 313 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total depreciation and amortization <sup>(B)</sup> | $**5699** | $4946 |
| Interest Expense (Income), net: |  |  |
| &nbsp;&nbsp;&nbsp;Electronics | $**149** | $255 |
| &nbsp;&nbsp;&nbsp;Stoneridge Brazil | **134** | (149) |
| &nbsp;&nbsp;&nbsp;Unallocated Corporate | **3402** | 3136 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest expense, net | $**3685** | $3242 |
| Capital Expenditures: |  |  |
| &nbsp;&nbsp;&nbsp;Electronics | $**3804** | $3880 |
| &nbsp;&nbsp;&nbsp;Stoneridge Brazil | **455** | 298 |
| &nbsp;&nbsp;&nbsp;Corporate <sup>(C)</sup> | **36** | 160 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total capital expenditures | $**4295** | $4338 |

---

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except per share data, unless otherwise stated)**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| Total Assets: |  |  |
| &nbsp;&nbsp;&nbsp;Electronics | $**408653** | $366258 |
| &nbsp;&nbsp;&nbsp;Stoneridge Brazil | **66022** | 60930 |
| &nbsp;&nbsp;&nbsp;Corporate <sup>(C)</sup> | **369679** | 410993 |
| &nbsp;&nbsp;&nbsp;Eliminations | **(332383)** | (287065) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $**511971** | $551116 |

---

The following tables present net sales and long-term assets for each of the geographic areas in which the Company operates:

---

| | | |
|:---|:---|:---|
| | **Three months ended March 31,** | **Three months ended March 31,** |
| | **2026** | **2025** |
| Net Sales: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;United States | $**46893** | $42769 |
| &nbsp;&nbsp;&nbsp;North America | $**46893** | $42769 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Brazil | **15999** | 14274 |
| &nbsp;&nbsp;&nbsp;South America | $**15999** | $14274 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sweden | **31872** | 38048 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Estonia | **38501** | 30198 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Netherlands | **26065** | 21789 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other Europe | **1138** | 1008 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;China | **379** | 971 |
| &nbsp;&nbsp;&nbsp;Europe and Other | $**97955** | $92014 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total net sales | $**160847** | $149057 |

---

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| Long-term Assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;United States | $**18993** | $18211 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mexico | **8292** | 28493 |
| &nbsp;&nbsp;&nbsp;North America | $**27285** | $46704 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Brazil | **31960** | 31191 |
| &nbsp;&nbsp;&nbsp;South America | $**31960** | $31191 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sweden | **32943** | 34962 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Estonia | **11654** | 11052 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Netherlands | **59741** | 61322 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other Europe | **388** | 439 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;China | **—** | 3650 |
| &nbsp;&nbsp;&nbsp;Europe and Other | $**104726** | $111425 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total long-term assets | $**163971** | $189320 |

---

__________________________________________________________

(A)Unallocated Corporate expenses include, among other items, accounting/finance, human resources, information technology and legal costs as well as share-based compensation.

(B)These amounts represent depreciation and amortization on property, plant and equipment and certain intangible assets.

(C)Assets located at Corporate consist primarily of cash, intercompany loan receivables, fixed assets for the corporate headquarter building, leased assets, information technology assets, equity investments and investments in subsidiaries.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**STONERIDGE, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(in thousands, except per share data, unless otherwise stated)**

**(Unaudited)**

**(15) Investments**

In December 2018, the Company entered into an agreement to make a $10,000 investment in a fund ("Autotech Fund II") managed by Autotech Ventures ("Autotech"), a venture capital firm focused on ground transportation technology which is accounted for under the equity method of accounting. The Company's $10,000 investment in the Autotech Fund II will be contributed over the expected ten-year life of the fund. The Company has contributed $9,330 to the Autotech Fund II as of March 31, 2026. The Company did not contribute to or receive distributions from Autotech Fund II during the three months ended March 31, 2026 and 2025, respectively. The Company has a 6.7% interest in Autotech Fund II. The Company recognized losses (gains) of $231 and $(294) during the three months ended March 31, 2026 and 2025, respectively. The Autotech Fund II investment recorded in investments and other long-term assets in the condensed consolidated balance sheets was $8,211 and $8,442 as of March 31, 2026 and December 31, 2025, respectively.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations**

We are a global supplier of safe and efficient electronics systems and technologies. Our systems and products power vehicle intelligence, while enabling safety and security for global commercial, off-highway, automotive and agricultural vehicle markets.

The following discussion and analysis should be read in conjunction with the condensed consolidated financial statements and notes related thereto and other financial information included elsewhere herein.

***Segments***

On December 31, 2025, we conducted our business in three reportable business segments, which were the same as our three operating segments: Control Devices, Electronics and Stoneridge Brazil. In January 2026, we completed the sale of the Control Devices segment, which is reflected as discontinued operations in all periods presented. As a result, we now operate our business in two reportable business segments, which are the same as our two operating segments.

We are organized by products produced and markets served. Under this structure, our operations have been reported using the following segments:

*Electronics.* This segment includes results of operations from the production of advanced driver information solutions, vision systems, connectivity and compliance solutions and control modules.

*Stoneridge Brazil.* This segment includes results of operations that design and manufacture vehicle tracking devices and monitoring services, driver information systems, vehicle security alarms and convenience accessories, telematics solutions and multimedia devices.

***First Quarter Overview***

The Company had net loss from continuing operations of $14.8 million, or $(0.53) per diluted share, for the three months ended March 31, 2026.

Net loss from continuing operations for the quarter ended March 31, 2026 increased by $6.8 million, or $(0.24) per diluted share, from net loss from continuing operations of $8.0 million, or $(0.29) per diluted share, for the three months ended March 31, 2025. Net sales increased by $11.8 million, or 7.9%, compared to the three months ended March 31, 2025, from the favorable impact of foreign currency translation, higher sales resulting from the Mexico Manufacturing Agreement related to the sale of Control Devices, and higher MirrorEye system sales. These increases were offset by a decrease in product sales to the European and North American commercial vehicle markets including lower sales for the Smart 2 tachograph due to the end of a regulatory retrofit campaign in 2025. Gross margin for the quarter ended March 31, 2026 decreased to 21.7% from 23.6% for the three months ended March 31, 2025 due to higher direct material costs in our Electronics segment from adverse sales mix and higher direct material labor costs. SG&A expense increased primarily due to higher share-based compensation expense from the retirement related accelerated vesting, Brazilian indirect taxes and higher legal expenses, which were offset by lower D&D expense from higher customer reimbursements in our Electronics segment. In addition, non-operating foreign currency losses unfavorably impacted results for the quarter ending March 31, 2026.

Our Electronics segment net sales increased by 7.5% compared to the first quarter of 2025 primarily due to favorable euro and Swedish krona foreign currency translation, higher MirrorEye system sales and higher sales of $3.8 million resulting from the Mexico Manufacturing Agreement related to the sale of Control Devices. These increases were offset by a decrease in product sales to the European and North American commercial vehicle markets including lower sales for the Smart 2 tachograph product. Segment gross margin decreased compared to the first quarter of 2025 from higher direct material costs as a percentage of sales from unfavorable sales mix and higher direct labor costs slightly offset by lower overhead spending including tariff recoveries and lower business realignment costs. Operating income for the segment decreased compared to the first quarter of 2025 because of lower gross profit and higher SG&A expense from higher wages and business realignment costs offset by lower D&D from higher customer reimbursements.

Our Stoneridge Brazil segment net sales increased by 12.1% compared to the first quarter of 2025 primarily from favorable foreign currency translation and higher OEM product sales. Operating income increased due to favorable variances from U.S. dollar denominated purchases and higher contribution from higher sales levels offset by higher SG&A from higher incentive compensation and Brazilian indirect taxes.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

In the first quarter of 2026, SG&A expenses increased by $6.7 million compared to the first quarter of 2025 driven primarily because of higher share-based compensation from retirement related accelerated vesting, Brazilian indirect taxes and higher legal expenses.

In the first quarter of 2026, D&D costs decreased by $2.3 million compared to the prior year first quarter in our Electronics segment as a result of higher customer reimbursements.

At March 31, 2026 and December 31, 2025, we had cash and cash equivalents balances primarily held at our foreign locations of $70.5 million and $53.1 million, respectively, and we had $156.5 million and $180.9 million, respectively, in borrowings outstanding on our Credit Facility. The 2026 decrease in Credit Facility borrowings and the increase in cash and cash equivalents was mostly due to proceeds received from the sale of Control Devices.

***Outlook***

Stoneridge's remaining portfolio, after the sale of the Control Devices business, will be focused on technology solutions primarily for the global commercial vehicle and off-highway end markets. More specifically, Stoneridge will serve three primary product categories: vision and safety, connectivity, and vehicle intelligence and electronic controls, each with their own significant growth opportunities. We expect continued expansion of our vision and safety systems, including MirrorEye® and adjacent products and advanced technologies, through maturity of our existing products and the introduction of new products to the market, including our connected trailer and surround-view capabilities. As we continue to invest in these capabilities, we have generated a comprehensive technology roadmap that we expect will both enhance and expand on our existing products and bring new products and technologies to the market. We expect this will drive growth that significantly outpaces our weighted-average end markets resulting in shareholder value creation.

Our financial performance has been affected by increasing costs of materials, labor, and other inputs used to manufacture and sell our products, including higher costs for memory and other semiconductor components. To minimize the impact of these incremental costs, we continue to take mitigation actions, including negotiating price increases and cost recoveries with our customers, improving manufacturing performance and optimizing our global cost structure to both reduce costs and improve operational efficiency. While we expect these actions will contribute to improved financial performance by offsetting cost pressures, there can be no assurance that our mitigation efforts will fully offset the impact of these cost increases.

In February 2026, the U.S. government imposed new tariffs on imported products from China and Mexico, in addition to tariffs imposed during 2025, and in April 2026 announced additional broad-based tariffs on imports from most U.S. trading partners. The Company has manufacturing and supply chain exposure from materials sourced from other countries and products produced in Mexico. If existing or proposed tariffs are sustained or expanded, they could materially increase our cost of goods sold and adversely affect our results of operations and cash flows. We continue to implement mitigation actions to reduce the impact of tariffs, including negotiating cost recoveries and price adjustments with our customers, evaluating alternative sourcing arrangements and assessing opportunities to adjust our manufacturing footprint. However, there can be no assurance that these actions will fully offset the incremental costs, and the ultimate impact will depend on the scope and duration of the tariffs and our ability to pass costs through to customers.

Based on IHS Markit production forecasts, in 2026 the European and North American commercial vehicle end market volumes are forecasted to increase 1.2% and 3.4%, respectively. Over the long-term, we expect our Electronics' segment sales to continue to outperform forecasted changes in production volumes due to strong demand for our existing products including our OEM MirrorEye programs in North America and Europe as well as from launches of awarded business. In addition, over the long-term we expect revenue growth and margin contribution from our off-highway products. We continue to focus on margin improvement through material cost reduction and product quality initiatives. We continue to invest in the development of advanced system capabilities that are complementary to our driver information solutions and vision systems such as integrated driver assistance technologies and an intelligent connected trailer system.

In April 2026, the International Monetary Fund forecasted the Brazil gross domestic product to grow 1.9% in 2026. We expect our served market channels to remain relatively stable in 2026 based on current market and economic conditions; however our sales of in-region OEM products are expected to increase in the second half of 2026 due to the launch of an awarded infotainment product. Stoneridge Brazil will focus on continuing to grow our OEM capabilities in-region to better support our global customers. This focus will provide opportunities for future growth and provide a platform to continue to rotate our local portfolio to more closely align with our global business.

In 2026, we expect net D&D spend to increase driven by spend for quality improvement and the development of next generation products. We continue to evaluate and optimize our engineering footprint to enhance capabilities and capacity for the most efficient return on our engineering spend including increasing the utilization of our Stoneridge Brazil engineering and dedicated engineering partners in India to support Electronics segment projects.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

While we expect continued supply chain challenges across our end markets in 2026, we continue to focus on operating performance and enterprise-wide cost reduction. We remain focused on improving cash generation and the reduction of debt through efficient operating performance, structural cost savings and targeted actions to reduce our inventory levels.

Our future effective tax rate depends on various factors, such as changes in tax laws, regulations, accounting principles and our jurisdictional mix of earnings. We monitor these factors and the impact on our effective tax rate.

***Other Matters***

A significant portion of our sales are outside of the United States. These sales are generated by our non-U.S. based operations, and therefore, movements in foreign currency exchange rates can have a significant effect on our results of operations, which are presented in U.S. dollars. A significant portion of our raw materials purchased by our Electronics and Stoneridge Brazil segments are denominated in U.S. dollars and, therefore, movements in foreign currency exchange rates can also have a significant effect on our results of operations. In the first quarter of 2026, the U.S. Dollar weakened against the Brazilian real favorably impacting our financial results while it strengthened against the Swedish krona and weakened against the Mexican peso which had an unfavorable impact to our reported results. In the first quarter of 2025, the U.S dollar strengthened against the Brazilian real unfavorably impacting our financial results while it weakened against the Swedish krona which had a favorable impact to our reported results.

In December 2018, the Company entered into an agreement to make a $10.0 million investment in a fund ("Autotech Fund II") managed by Autotech Ventures ("Autotech"), a venture capital firm focused on ground transportation technology. The Company's $10.0 million investment in the Autotech Fund II will be contributed over the expected ten-year life of the fund. The Company has contributed $9.3 million to the Autotech Fund II since December 2018.

We regularly evaluate the performance of our businesses and their cost structures, including personnel, and make necessary changes thereto to optimize our results. We also evaluate the required skill sets of our personnel and periodically make strategic changes. Because of these actions, we incur severance and resignation related costs that we refer to as business realignment charges. Business realignment costs of $0.4 million and $2.5 million were incurred in the three months ended March 31, 2026 and 2025, respectively. For the three months ended March 31, 2025, we incurred $1.4 million in business realignment costs related to operational efficiency initiatives at our Juarez facility. We may incur additional realignment costs in the future.

Because of the competitive nature of the markets we serve, we face pricing pressures from our customers in the ordinary course of business. In response to these pricing pressures, we have been able to manage our production costs through a combination of negotiated cost recoveries with customers, material cost reduction initiatives and optimization of our global manufacturing footprint, the net impact of which to date has not been material to our results of operations. However, these efforts may not be sufficient to fully offset future pricing pressures, particularly in light of current macroeconomic conditions, including tariffs and supply chain disruptions, and if we are unable to effectively manage production costs, our results of operations could be adversely affected.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

***Three Months Ended March 31, 2026 Compared to Three Months Ended March 31, 2025***

Condensed consolidated statements of operations as a percentage of net sales are presented in the following table (in thousands):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Three months ended March 31,** | **2026** | **2026** | **2025** | **2025** | **Dollar<br>increase<br>(decrease)** |
| Net sales | $**160847** | **100.0%** | $149057 | 100.0% | $11790 |
| Costs and expenses: |  |  |  |  |  |
| &nbsp;&nbsp;Cost of goods sold | **125891** | **78.3** | 113807 | 76.4 | 12084 |
| &nbsp;&nbsp;Selling, general and administrative | **32529** | **20.2** | 25865 | 17.4 | 6664 |
| &nbsp;&nbsp;Design and development | **11405** | **7.1** | 13691 | 9.2 | (2286) |
| Operating loss | **(8978)** | **(5.6)** | (4306) | (2.9) | (4672) |
| &nbsp;&nbsp;Interest expense, net | **3685** | **2.3** | 3242 | 2.2 | 443 |
| &nbsp;&nbsp;Equity in loss (earnings) of investee | **231** | **0.1** | (294) | (0.2) | 525 |
| &nbsp;&nbsp;Other expense (income), net | **470** | **0.3** | (825) | (0.6) | 1295 |
| Loss before income taxes from continuing operations | **(13364)** | **(8.3)** | (6429) | (4.3) | (6935) |
| Provision for income taxes from continuing operations | **1414** | **0.9** | 1575 | 1.1 | (161) |
| Loss from continuing operations | **(14778)** | **(9.2)** | (8004) | (5.4) | (6774) |
| Discontinued operations: |  |  |  |  |  |
| &nbsp;&nbsp;Loss (income) from discontinued operations, net of tax | **3322** | **2.1** | (808) | (0.5) | 4130 |
| &nbsp;&nbsp;Loss on disposal, net of tax | **9817** | **6.1** |  |  | 9817 |
| Loss (income) from discontinued operations | **13139** | **8.2** | (808) | (0.5) | 13947 |
| Net loss | $**(27917)** | **(17.4)%** | $(7196) | (4.8)% | $(20721) |

---

*Net Sales.* Net sales for our reportable segments, excluding inter-segment sales, are summarized in the following table (in thousands):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Three months ended March 31,** | **2026** | **2026** | **2025** | **2025** | **Dollar<br>increase** | **Percent<br>increase** |
| Electronics | $**144848** | **90.1%** | $134783 | 90.4% | $10065 | 7.5% |
| Stoneridge Brazil | **15999** | **9.9** | 14274 | 9.6 | 1725 | 12.1% |
| &nbsp;&nbsp;&nbsp;Total net sales | $**160847** | **100.0%** | $149057 | 100.0% | $11790 | 7.9% |

---

Our Electronics segment net sales increased $10.1 million because of favorable euro and Swedish krona foreign currency translation of $12.3 million and higher sales of $3.8 million resulting from the Mexico Manufacturing Agreement related to the sale of Control Devices. Additionally, sales increased in our North American commercial vehicle market by $0.9 million driven by higher MirrorEye system sales partially offset by lower customer production volumes. These increases were offset by lower sales volumes in our European commercial vehicle market of $7.4 million, primarily due to lower sales for the Smart 2 tachograph product resulting from the end of a retrofit campaign in 2025, and lower customer production volumes partially offset by higher MirrorEye system sales.

Our Stoneridge Brazil segment net sales increased $1.7 million from favorable foreign currency translation and higher OEM product sales.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

Net sales by geographic location are summarized in the following table (in thousands):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Three months ended March 31,** | **2026** | **2026** | **2025** | **2025** | **Dollar<br>increase** | **Percent<br>increase** |
| North America | $**46893** | **29.2%** | $42769 | 28.7% | $4124 | 9.6% |
| South America | **15999** | **9.9** | 14274 | 9.6 | 1725 | 12.1% |
| Europe and Other | **97955** | **60.9** | 92014 | 61.7 | 5941 | 6.5% |
| &nbsp;&nbsp;&nbsp;Total net sales | $**160847** | **100.0%** | $149057 | 100.0% | $11790 | 7.9% |

---

The increase in North American net sales was due to an increase in sales resulting from the Mexico Manufacturing Agreement related to the sale of Control Devices and higher MirrorEye system sales.

The increase in net sales in South America was from favorable foreign currency translation and higher OEM product sales.

The increase in net sales in Europe and Other was due to favorable foreign currency translation of $12.3 million, higher MirrorEye system sales and an increase in volume in our European off-highway market sales of $1.9 million. These increases were offset by lower sales volumes in our European commercial vehicle market of $7.4 million, including lower Smart 2 tachograph product sales from the end of a regulatory retrofit campaign in 2025.

*Cost of Goods Sold and Gross Margin.* Cost of goods sold increased compared to the first quarter of 2025 and our gross margin decreased to 21.7% in the first quarter of 2026 from 23.6% in the first quarter of 2025. Our material cost as a percentage of net sales increased to 58.3% in the first quarter of 2026 from 56.2% in the first quarter of 2025. The increase in material cost percentage was due to unfavorable sales mix in our Electronics segment from lower Smart 2 tachograph sales. Overhead as a percentage of net sales decreased from 16.6% in the first quarter of 2025 to 15.2% in the first quarter of 2026 due to tariff recoveries and lower business realignment costs in our Electronics segment.

Our Electronics segment gross margin decreased compared to the prior year first quarter from higher direct material costs as a percentage of sales from unfavorable sales mix offset by lower overhead spending including tariff recoveries and lower business realignment costs.

Our Stoneridge Brazil segment gross margin increased from the favorable material variances from U.S. dollar denominated purchases and favorable leverage of fixed costs from higher sales levels.

*Selling, General and Administrative.* SG&A expenses increased by $6.7 million primarily because of higher share-based compensation from retirement related accelerated vesting, Brazilian indirect taxes and legal expenses.

*Design and Development.* D&D costs decreased by $2.3 million compared to the first quarter of 2025 in our Electronics segment as a result of higher customer reimbursements.

*Operating Loss.* Operating (loss) income by segment is summarized in the following table (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Three months ended March 31,** | **2026** | **2025** | **Dollar<br>increase<br>(decrease)** | **Percent<br>increase <br>(decrease)** |
| Electronics | $**3732** | $5505 | $(1773) | (32.2)% |
| Stoneridge Brazil | **1321** | 585 | 736 | 125.8% |
| Unallocated corporate | **(14031)** | (10396) | (3635) | (35.0)% |
| &nbsp;&nbsp;&nbsp;Operating loss | $**(8978)** | $(4306) | $(4672) | 108.5% |

---

Our Electronics segment operating income decreased because of lower gross margin and higher SG&A expense from higher wages and business realignment costs offset by lower D&D from higher customer reimbursements.

Our Stoneridge Brazil segment operating income increased due to favorable variances from U.S. dollar denominated purchases and higher contribution from higher sales levels offset by higher SG&A from higher incentive compensation and Brazilian indirect taxes.

Our unallocated corporate operating loss increased from higher SG&A related to higher share-based compensation from retirement related accelerated vesting and legal fees offset by lower business realignment costs as well as D&D spending.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

Operating (loss) income by geographic location is summarized in the following table (in thousands):

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Three months ended March 31,** | **2026** | **2025** | **Dollar**<br>**increase (decrease)** | **Percent**<br>**increase (decrease)** |
| North America | $**(14070)** | $(11463) | $(2607) | (22.7)% |
| South America | **1321** | 585 | 736 | 125.8% |
| Europe and Other | **3771** | 6579 | (2808) | (42.7)% |
| &nbsp;&nbsp;&nbsp;Operating loss | $**(8978)** | $(4299) | $(4679) | 108.8% |

---

Our North American operating loss increased due to higher SG&A from higher share-based compensation from retirement-related accelerated vesting and higher D&D expense offset by higher gross margin from higher sales levels and tariff recoveries. Operating income in South America increased from higher gross margin from higher sales levels offset by higher SG&A from higher incentive compensation and Brazilian indirect taxes. Our operating results in Europe and Other decreased because of lower margin from adverse sales mix and higher SG&A spending from higher business realignment costs offset by lower D&D expense from higher customer reimbursements.

*Interest Expense, net.* Interest expense, net was $3.7 million and $3.2 million for the three months ended March 31, 2026 and 2025, respectively. The increase for the quarter ended March 31, 2026, was the result of higher Credit Facility interest rates partially offset by lower outstanding Credit Facility borrowings.

*Equity in Loss (Earnings) of Investee.* Equity loss (earnings) for Autotech Fund II was $0.2 million and $(0.3) million for the three months ended March 31, 2026 and 2025, respectively.

*Other Expense (Income), net*. We record certain foreign currency transaction (gains) losses as a component of other expense (income), net on the condensed consolidated statement of operations. Other expense, net of $0.5 million increased by $1.3 million compared to the first quarter of 2025 due to foreign currency transaction losses in our Electronics segment from the weakening of the U.S. dollar.

*Provision for Income Taxes.* For the three months ended March 31, 2026, income tax expense from continuing operations of $1.4 million was attributable to the mix of earnings among tax jurisdictions, tax credits and incentives and valuation allowances in certain jurisdictions. The effective tax rate of (10.6)% varies from the statutory tax rate primarily due to tax credits and incentives and valuation allowances in certain jurisdictions.

For the three months ended March 31, 2025, income tax expense from continuing operations of $1.6 million was attributable to the mix of earnings among tax jurisdictions, the impact of valuation allowances in certain jurisdictions and tax credits and incentives offset by U.S. taxes on foreign earnings. The effective tax rate of (24.5)% varies from the statutory tax rate primarily due to the impact of valuation allowances in certain jurisdictions and tax credits and incentives offset by U.S. taxes on foreign earnings.

***Liquidity and Capital Resources***

*Summary of Cash Flows:*

---

| | | |
|:---|:---|:---|
| **Three Months Ended March 31, 2026** | **2026** | **2025** |
| Net cash provided by (used for) from continuing operations: |  |  |
| &nbsp;&nbsp;Operating activities | $**(11499)** | $10089 |
| &nbsp;&nbsp;Investing activities | **58393** | (5988) |
| &nbsp;&nbsp;Financing activities | **(25486)** | (787) |
| Cash (used for) provided by discontinued operations: | **(3322)** | 808 |
| Effect of exchange rate changes on cash and cash equivalents | **(607)** | 3155 |
| &nbsp;&nbsp;&nbsp;Net change in cash and cash equivalents | $**17479** | $7277 |

---

Cash used for operating activities increased compared to 2025 because of a higher net loss and higher working capital levels primarily accounts receivable slightly offset by accounts payable. Cash used by receivables increased due to receivables resulting from manufacturing and transition service agreements related to the sale of Control Devices in the first quarter of 2026, however overall collection terms have remained consistent.

Net cash provided by investing activities increased compared to 2025 due to the proceeds from the sale of Control Devices offset by lower capital expenditures.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

Net cash used for financing activities increased compared to 2025 due to an increase in Credit Facility repayments from proceeds from the sale of Control Devices.

As outlined in Note 7 to our condensed consolidated financial statements, the Credit Facility permitted borrowing up to a maximum level of $275.0 million. This variable rate facility had an accordion feature which allowed the Company to increase its availability by up to $150.0 million upon the satisfaction of certain conditions and lender consent through its expiration in November 2026. The Credit Facility contains certain financial covenants that require the Company to maintain less than a maximum leverage ratio and more than a minimum interest coverage ratio. The Credit Facility also contains affirmative and negative covenants and events of default that are customary for credit arrangements of this type including covenants that place restrictions and/or limitations on the Company's ability to borrow money, make capital expenditures and pay dividends. The Credit Facility had an outstanding balance of $156.5 million at March 31, 2026.

On February 26, 2025, the Company entered into Amendment No. 1 to the Fifth Amended and Restated Credit Agreement and Waiver ("Amendment No. 1"). Amendment No. 1 provided for certain covenant relief and restrictions during the "Covenant Relief Period" (the period ending on the date that the Company delivers a compliance certificate for the quarter ending December 31, 2025). During the Covenant Relief Period:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the maximum leverage ratio of 3.50 was increased to 6.00 for the quarter ended March 31, 2025, 5.50 for the quarter ended June 30, 2025, 4.50 for the quarter ended September 30, 2025 and 3.50 for the quarter ended December 31, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the minimum interest coverage ratio of 3.50 was waived for the quarter ended December 31, 2024 and was reduced to 2.00 for the quarters ended March 31 and June 30, 2025, and 2.50 and 3.50 for the quarter ended September 30, 2025 and December 31, 2025, respectively;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Company's aggregate amount of cash and cash equivalents, defined as 100% of North American and 65% of foreign cash balances, cannot exceed $70.0 million;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the sale of significant assets (as defined) will require repayment in the amount of any net cash proceeds received and result in the reduction of the Credit Facility commitment, at the lesser of $100.0 million or the net cash proceeds;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• there were certain restrictions on Restricted Payments (as defined); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a Permitted Acquisition (as defined) could not be consummated unless otherwise approved in writing by the required lenders.

Amendment No. 1 added an additional level to the leverage ratio based pricing grid, through maturity, when the leverage ratio is greater than 3.50.

On November 5, 2025, the Company entered into Amendment No. 2 to the Fifth Amended and Restated Credit Agreement and Consent Agreement ("Amendment No. 2"). Amendment No. 2 amended the Credit Facility and provided for certain covenant relief and restrictions through the Credit Facility's termination date of November 2, 2026. Amendment No. 2 superseded certain terms of the Credit Facility and Amendment No. 1 beginning November 5, 2025 and ending at the Credit Facility's termination date of November 2, 2026. Amendment No. 2 amended certain Credit Facility terms and provides covenant relief as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• borrowing capacity is reduced from $275.0 million to $225.0 million;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the sale of the Control Devices business (as defined) is a permitted transaction and upon notice will result in the reduction of the Credit Facility commitment, at the lesser of $50.0 million or the net cash proceeds of this transaction;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the current minimum interest coverage ratio of 2.5 was extended through the quarter ending March 31, 2026 and increased to 3.5 for the quarter ended June 30, 2026 and thereafter;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;◦ if the Control Devices business sale is consummated, the minimum interest coverage ratio will increase to 3.5 as of the last day of the first full quarter ending after the sale and thereafter; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the maximum leverage ratio of 4.5 for the quarter ended September 30, 2025 and 3.5 for the quarter ended December 31, 2025 and thereafter remains unchanged.

On January 30, 2026, as a result of the sale of the Control Devices business, the Credit Facility borrowing capacity was reduced from $225.0 million to $175.0 million.

On March 6, 2026, the Company entered into Amendment No. 3 to the Fifth Amended and Restated Credit Agreement ("Amendment No. 3"). Amendment No. 3 amends and restates the Credit Facility in its entirety beginning December 31, 2025 and ending at the Credit Facility's amended termination date of July 1, 2027. Amendment No. 3 also provides for certain covenant relief and adjustments to terms and conditions as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• expiration date of the Credit Facility is extended from November 2, 2026 to July 1, 2027;

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the current minimum interest coverage ratio of 2.50 was reduced to 1.60 for the quarter ended March 31, 2026, 1.70 for the quarter ended June 30, 2026, 1.75 for the quarter ended September 30, 2026 and 2.50 for the quarter ended December 31, 2026 and thereafter;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the maximum leverage ratio was increased to 3.75 for the quarter ended December 31, 2025, increases to 6.25 for the quarter ended March 31, 2026, 6.75 for the quarter ended June 30, 2026, 6.00 for the quarter ended September 30, 2026 and 4.00 for the quarter ended December 31, 2026 and thereafter;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• on December 31, 2026, the current borrowing capacity of $175.0 million will be reduced to the lesser of $157.5 million or the then current Credit Facility commitment;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• modifications to Consolidated EBITDA (as defined); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• modifications and additions to affirmative covenants.

The Company was in compliance with all covenants at March 31, 2026 and December 31, 2025. The Company has not experienced a violation that would limit the Company's ability to borrow under the Credit Facility, as amended, and does not expect that the covenants under it will restrict the Company's financing flexibility. However, it is possible that future borrowing flexibility under the Credit Facility may be limited as a result of lower than expected financial performance due to the adverse impact of significantly lower global demand in our markets and challenging macroeconomic conditions. The Company expects to make additional repayments on the Credit Facility when cash exceeds the amount needed for operations and to remain in compliance with all covenants.

The Company's wholly owned subsidiary located in Stockholm, Sweden, has an overdraft credit line that allows overdrafts on the subsidiary's bank account up to a daily maximum level of 20.0 million Swedish krona, or $2.1 million and $2.2 million at March 31, 2026 and December 31, 2025, respectively. At March 31, 2026 and December 31, 2025, there were no borrowings outstanding on this overdraft credit line. During the three months ended March 31, 2026, the subsidiary borrowed and repaid 21.8 million Swedish krona, or $2.6 million. The Stockholm subsidiary has pledged certain of its assets as collateral in order to obtain a guarantee of certain of the Stockholm subsidiary's obligations to third parties.

In December 2018, the Company entered into an agreement to make a $10.0 million investment in Autotech Fund II managed by Autotech, a venture capital firm focused on ground transportation technology. The Company's $10.0 million investment in the Autotech Fund II will be contributed over the expected ten-year life of the fund. As of March 31, 2026, the Company's cumulative investment in the Autotech Fund II was $9.3 million. The Company did not contribute to Autotech Fund II during the three months ended March 31, 2026 or March 31, 2025, respectively.

Our future results could also be adversely affected by unfavorable changes in foreign currency exchange rates. We have significant foreign denominated transaction exposure in certain locations, especially in Brazil, Argentina, Mexico, Sweden, Estonia, the Netherlands, United Kingdom and China. Our future results could also be unfavorably affected by increased commodity prices and material cost inflation as these fluctuations impact the cost of our raw material purchases.

At March 31, 2026, we had a cash and cash equivalents balance of approximately $70.5 million, of which 79.1% was held in foreign locations. The Company has approximately $18.5 million of undrawn commitments under the Credit Facility as of March 31, 2026, which results in total undrawn commitments and cash balances of approximately $89.1 million. However, it is possible that future borrowing flexibility under our Credit Facility may be limited as a result of our financial performance.

The principal sources of liquidity available for our future cash requirements are expected to be (i) cash flows from operations, (ii) cash and cash equivalents on-hand and (iii) borrowings from our Credit Facility. We believe that our overall liquidity and operating cash flow will be sufficient to meet our anticipated cash requirements for capital expenditures, working capital and other commitments during the next twelve months. While uncertainty surrounding the current economic environment could adversely impact our business, based on our current financial position, we believe it is unlikely that any such effects would preclude us from maintaining sufficient liquidity.

***Commitments and Contingencies***

See Note 11 to the condensed consolidated financial statements for disclosures of the Company's commitments and contingencies.

***Seasonality***

Our Electronics segment is moderately seasonal, impacted by mid-year and year-end shutdowns and the ramp-up of new model production at key customers. In addition, the demand for our Stoneridge Brazil segment consumer products is generally higher in the second half of the year.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

***Critical Accounting Policies and Estimates***

The Company's critical accounting policies, which include management's best estimates and judgments, are included in Part II, Item 7, to the consolidated financial statements of the Company's 2025 <u>[Form 10-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/1043337/000104333726000023/sri-20251231.htm)</u>. These accounting policies are considered critical as disclosed in the Critical Accounting Policies and Estimates section of Management's Discussion and Analysis of the Company's 2025 <u>[Form 10-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/1043337/000104333726000023/sri-20251231.htm)</u> because of the potential for a significant impact on the financial statements due to the inherent uncertainty in such estimates. There have been no material changes in our significant accounting policies or critical accounting estimates during the first quarter of 2026.

Information regarding other significant accounting policies is included in Note 2 to our consolidated financial statements in Item 8 of Part II of the Company's 2025 <u>[Form 10-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/1043337/000104333726000023/sri-20251231.htm)</u>.

***International Presence***

By operating internationally, we are affected by foreign currency exchange rates and the economic conditions of certain countries. Furthermore, given the current economic climate and fluctuations in certain commodity prices, we believe that an increase in such items could significantly affect our profitability. See Note 6 to the condensed consolidated financial statements for additional details on the Company's foreign currency exchange rate risks.

**Item 3. Quantitative and Qualitative Disclosures About Market Risk**

There have been no material changes to the quantitative and qualitative information about the Company's market risk from those previously presented within Part II, Item 7A of the Company's 2025 <u>[Form 10-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/1043337/000104333726000023/sri-20251231.htm)</u>.

**Item 4. Controls and Procedures**

**Evaluation of Disclosure Controls and Procedures**

As of March 31, 2026, an evaluation was performed under the supervision and with the participation of the Company's management, including the principal executive officer ("PEO") and principal financial officer ("PFO"), of the effectiveness of the design and operation of the Company's disclosure controls and procedures. Based on that evaluation, the Company's management, including the PEO and PFO, concluded that the Company's disclosure controls and procedures were effective as of March 31, 2026.

**Changes in Internal Control Over Financial Reporting**

There were no changes in the Company's internal control over financial reporting during the three months ended March 31, 2026 that materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**PART II–OTHER INFORMATION**

**Item 1. Legal Proceedings**

We are involved in certain legal actions and claims primarily arising in the ordinary course of business. We establish accruals for matters that we believe that losses are probable and can be reasonably estimated. Although it is not possible to predict with certainty the outcome of these matters, we do not believe that any of the litigation in which we are currently engaged, either individually or in the aggregate, will have a material adverse effect on our business, consolidated financial position or results of operations. We are subject to litigation regarding civil, labor, regulatory and other tax contingencies in our Stoneridge Brazil segment that we believe the likelihood of loss is reasonably possible, but not probable, although these claims might take years to resolve. We are also subject to product liability and product warranty claims. In addition, if any of our products prove to be defective, we may be required to participate in a government-imposed or customer OEM-instituted recall involving such products. There can be no assurance that we will not experience any material losses related to product liability, warranty or recall claims. See additional details of these matters in Note 11 to the condensed consolidated financial statements.

**Item 1A. Risk Factors**

There have been no material changes with respect to risk factors previously disclosed in the Company's 2025 <u>[Form 10-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/1043337/000104333726000023/sri-20251231.htm)</u>.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds**

The Company did not sell any unregistered equity securities during the quarter ended March 31, 2026.

The following table presents information with respect to repurchases of Common Shares made by us during the three months ended March 31, 2026. There were 30,235 Common Shares delivered to us by employees as payment for withholding taxes due upon vesting of performance share awards and share unit awards. These shares were acquired from employees solely to satisfy tax withholding obligations in connection with the vesting of equity awards. These acquisitions were not made pursuant to any publicly announced repurchase plan or program, and the Company did not have any such repurchase plans or programs in effect during the quarter.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total number of<br>shares purchased** | **Average price<br>paid per share** | **Total number of<br>shares purchased as<br>part of publicly<br>announced plans<br>or programs** | **Maximum number<br>of shares that may<br>yet be purchased<br>under the plans<br>or programs** |
| 1/1/26-1/31/26 | **23** | $**5.79** | **N/A** | **N/A** |
| 2/1/26-2/28/26 | **—** | $**—** | **N/A** | **N/A** |
| 3/1/26-3/31/26 | **30212** | $**7.69** | **N/A** | **N/A** |
| Total | **30235** |  |  |  |

---

**Item 3. Defaults Upon Senior Securities**

None.

**Item 4. Mine Safety Disclosures**

None.

**Item 5. Other Information**

During the quarter ended March 31, 2026, no director or officer of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

In addition, during the quarter ended March 31, 2026, the Company did not adopt or terminate any Rule 10b5-1 trading arrangement, as described in Item 408(b) of Regulation S-K.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**Item 6. Exhibits**

---

| | | |
|:---|:---|:---|
| **Exhibit<br>Number** | **Exhibit** | **Exhibit** |
| 10.1 | <u>[Stoneridge, Inc. 2025 Long-Term Incentive Plan Special Phantom Share Grant Agreement, dated January 31, 2026, filed herewith](sri-20260301xexx101.htm)[\*](sri-20260301xexx101.htm)[.](sri-20260301xexx101.htm)</u> | <u>[Stoneridge, Inc. 2025 Long-Term Incentive Plan Special Phantom Share Grant Agreement, dated January 31, 2026, filed herewith](sri-20260301xexx101.htm)[\*](sri-20260301xexx101.htm)[.](sri-20260301xexx101.htm)</u> |
| 10.2 | <u>[Recognition and Retention Bonus Letter, dated March 17, 2026 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on March 23, 2026)](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000031/sri-2026322xxexx101recogni.htm)[\*](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000031/sri-2026322xxexx101recogni.htm)[.](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000031/sri-2026322xxexx101recogni.htm)</u> | <u>[Recognition and Retention Bonus Letter, dated March 17, 2026 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on March 23, 2026)](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000031/sri-2026322xxexx101recogni.htm)[\*](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000031/sri-2026322xxexx101recogni.htm)[.](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000031/sri-2026322xxexx101recogni.htm)</u> |
| 10.3 | <u>[Amendment No. 3 to the Fifth Amended and Restated Credit Agreement, dated March 6, 2026 (incorporated by reference to](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000016/sri-2026311xexx101creditfa.htm)[Exhibit 10.1 to](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000016/sri-2026311xexx101creditfa.htm)[the Company's Current Report on Form 8-K filed on March](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000016/sri-2026311xexx101creditfa.htm)[11](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000016/sri-2026311xexx101creditfa.htm)[, 2026).](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000016/sri-2026311xexx101creditfa.htm)</u> | <u>[Amendment No. 3 to the Fifth Amended and Restated Credit Agreement, dated March 6, 2026 (incorporated by reference to](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000016/sri-2026311xexx101creditfa.htm)[Exhibit 10.1 to](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000016/sri-2026311xexx101creditfa.htm)[the Company's Current Report on Form 8-K filed on March](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000016/sri-2026311xexx101creditfa.htm)[11](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000016/sri-2026311xexx101creditfa.htm)[, 2026).](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000016/sri-2026311xexx101creditfa.htm)</u> |
| 10.4 | <u>[Cooperation Agreement (incorporated by reference to Exhibit 10.1 to the Company's Current Report on F](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000014/sri-2026226xxexx101coopera.htm)[or](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000014/sri-2026226xxexx101coopera.htm)[m 8-K filed on February 23, 2026).](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000014/sri-2026226xxexx101coopera.htm)</u> | <u>[Cooperation Agreement (incorporated by reference to Exhibit 10.1 to the Company's Current Report on F](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000014/sri-2026226xxexx101coopera.htm)[or](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000014/sri-2026226xxexx101coopera.htm)[m 8-K filed on February 23, 2026).](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000014/sri-2026226xxexx101coopera.htm)</u> |
| 10.5 | <u>[Stock Purchase Agreement, dated as of January 30, 2026, by and among Stoneridge, Inc., Stoneridge Electronics, Inc., and Control Devices Acquisition, LLC (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K filed on February 2, 2026).](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000002/sri-202622xxexx21stockpurc.htm)</u> | <u>[Stock Purchase Agreement, dated as of January 30, 2026, by and among Stoneridge, Inc., Stoneridge Electronics, Inc., and Control Devices Acquisition, LLC (incorporated by reference to Exhibit 2.1 to the Company's Current Report on Form 8-K filed on February 2, 2026).](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000002/sri-202622xxexx21stockpurc.htm)</u> |
| 10.6 | <u>[Mexico Manufacturing Agreement, dated as of January 30, 2026, by and between Stoneridge Electronics, Inc., and Stoneridge Control Devices, Inc. (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on February 2, 2026).](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000002/sri-202622xxexx101mexicoma.htm)</u> | <u>[Mexico Manufacturing Agreement, dated as of January 30, 2026, by and between Stoneridge Electronics, Inc., and Stoneridge Control Devices, Inc. (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed on February 2, 2026).](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000002/sri-202622xxexx101mexicoma.htm)</u> |
| 10.7 | <u>[China Manufacturing Agreement, dated as of January 30, 2026, by and between Stoneridge Electronics AS and Stoneridge Asia Pacific Electronics (Suzhou) Co. Ltd. (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 2, 2026).](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000002/sri-202622xxexx102chinaman.htm)</u> | <u>[China Manufacturing Agreement, dated as of January 30, 2026, by and between Stoneridge Electronics AS and Stoneridge Asia Pacific Electronics (Suzhou) Co. Ltd. (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed on February 2, 2026).](https://www.sec.gov/Archives/edgar/data/1043337/000104333726000002/sri-202622xxexx102chinaman.htm)</u> |
| 31.1 | <u>[Chief Executive Officer certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.](sri-20260331xexx311.htm)</u> | <u>[Chief Executive Officer certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.](sri-20260331xexx311.htm)</u> |
| 31.2 | <u>[Chief Financial Officer certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.](sri-20260331xexx312.htm)</u> | <u>[Chief Financial Officer certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith.](sri-20260331xexx312.htm)</u> |
| 32.1 | <u>[Chief Executive Officer certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, filed herewith.](sri-20260331xexx321.htm)</u> | <u>[Chief Executive Officer certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, filed herewith.](sri-20260331xexx321.htm)</u> |
| 32.2 | <u>[Chief Financial Officer certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, filed herewith.](sri-20260331xexx322.htm)</u> | <u>[Chief Financial Officer certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, filed herewith.](sri-20260331xexx322.htm)</u> |
|  | 101 | **XBRL Exhibits:** |
|  | 101.INS | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document |
|  | 101.SCH | XBRL Taxonomy Extension Schema Document |
|  | 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document |
|  | 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document |
|  | 101.LAB | XBRL Taxonomy Extension Label Linkbase Document |
|  | 104 | The cover page from our Quarterly Report on Form 10-Q for the period ended March 31, 2026, filed with the Securities and Exchange Commission on May 15, 2026, is formatted in Inline Extensible Business Reporting Language ("iXBRL") |

---

_______________________

\* Reflects management contract or compensatory plan or arrangement.

------

<u>[**Table of Contents**](#if930f674aeb44051bc7e87b8feb3c2eb_7)</u>

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| | **STONERIDGE, INC.** |
| Date: May 15, 2026 | /s/ Natalia Noblet |
|  | Natalia Noblet |
|  | President, Chief Executive Officer and Director |
|  | (Principal Executive Officer) |
| Date: May 15, 2026 | /s/ Robert J. Hartman Jr. |
|  | Robert J. Hartman Jr. |
|  | Interim Chief Financial Officer and Treasurer |
|  | (Principal Financial Officer) |

---

## Exhibit 10.1

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Exhibit 10.1**

**STONERIDGE, INC.** 

**2025 LONG-TERM INCENTIVE PLAN**

**SPECIAL PHANTOM SHARE GRANT AGREEMENT**

**January 31, 2026**

Stoneridge, Inc., an Ohio corporation (the "Company"), pursuant to the terms and conditions hereof, hereby grants to [[FIRSTNAME]] [[LASTNAME]] ("Grantee") the right to receive an amount of cash equal to the value of [[SHARESGRANTED]] Common Shares, without par value, of the Company (the "Phantom Shares"). The grant of Phantom Shares (the "Award"), as embodied by this Agreement (the "Agreement"), is described below.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;The Phantom Shares are in all respects subject to the terms, conditions and provisions of this Agreement and Stoneridge, Inc. 2025 Long-Term Incentive Plan (the "Plan").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;The Phantom Shares shall be phantom (notional) Common Shares of the Company. Subject to the satisfaction of the applicable criteria, a Phantom Share shall entitle Grantee to the right to an amount of cash equal to (i) the Fair Market Value of a Common Share as of the Vesting Date (as set forth in Section 3 below), plus (ii) any Dividend Equivalent Rights ("DERs") relating to the Phantom Shares. Such amount in satisfaction of the vested Phantom Shares and related DERs shall be paid to Grantee in cash, less withholding obligations, as promptly as practical on or after January 31, 2027 ("Vesting Date").

For purposes of this Agreement, DERs shall mean a contingent right, automatically granted in tandem with a Phantom Share, to the right to an amount in cash equal to the cash distributions made by the Company with respect to Common Shares during the period from January 31, 2026, through January 31, 2027, and subject to the same vesting conditions as the related Phantom Shares. The Company shall track DERs by providing to Grantee a credit under a bookkeeping account (without interest) equal to cash distributions made by the Company with respect to Common Shares at the respective time(s) such distributions are made to holders of Common Shares.

For purpose of this Agreement, "Fair Market Value" of a Common Share shall mean as of a given date (in order of applicability): (i) the closing price of a Common Share on the principal exchange on which the Common Shares are then trading, if any, on the day immediately prior to such date, or if Common Shares were not traded on the day previous to such date, then on the next preceding trading day during which a sale occurred; or (ii) if Common Shares are not traded on an exchange but are quoted on NASDAQ or a successor quotation system, (A) the last sale price (if Common Shares are then listed as a National Market Issue under the NASD National Market System) or (B) if Common Shares are not then so listed, the mean between the closing representative bid and asked prices for Common Shares on the day previous to such date as reported by NASDAQ or such successor quotation system; or (iii) if Common Shares are not publicly traded on an exchange and not quoted on NASDAQ or a successor quotation system, the mean between the closing bid and asked prices for Common Shares, on the day previous to such date, as determined in good faith by the Compensation Committee of the Board of Directors (the "Committee"); or (iv) if Common Shares are not publicly traded, the fair market value established by the Committee acting in good faith.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;The Phantom Shares may not be sold, transferred, pledged, assigned or otherwise encumbered, whether voluntarily, involuntarily or by operation of law, and, except in

------

the cases described in Sections 3(a) – (d) below, will be forfeited to the Company on January 31, 2027 if the Grantee is not employed with the Company on the Vesting Date. If the Grantee is employed by the Company on the Vesting Date, the Phantom Shares shall vest and will no longer be subject to a substantial risk of forfeiture.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)<u>Retirement</u>. In the case of retirement, and subject to the conditions in the next paragraph, the Phantom Shares granted shall not be forfeited because of the retirement but shall vest on the date of retirement and no longer be subject to a substantial risk of forfeiture.

Only a Grantee who (i) is 63 or older at the time of retirement, (ii) has provided written notice to the Committee of the intent to retire at least three (3) months prior to the retirement date, and (iii) has executed prior to retirement a customary one-year non-competition agreement, shall be permitted to vest Phantom Shares upon said retirement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)<u>Death or Permanent Disability</u>. In the case of the Grantee's Death or Permanent Disability (as defined in the Plan), the Phantom Shares granted shall not be forfeited because of the Death or Permanent Disability but shall vest will vest on the date of Death or Permanent Disability in proportion to the number of months, including any partial month, elapsed in the vesting period divided by 12.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)<u>Change in Control</u>. In the case of (i) a Change in Control of the Company (as defined in the Plan), and (ii) within 24 months of such Change in Control the Grantee is terminated other than for cause, the Phantom Shares shall not be forfeited because of the Change in Control and termination but shall vest and no longer be subject to a substantial risk of forfeiture on the date of said termination.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)<u>Termination Without Cause</u>. In the case of the termination of Grantee's employment by the Company "without cause" (as defined in the next Sections 3(d)(1)-(2)) the Phantom Shares shall not be forfeited because of the termination but shall vest in proportion to the number of months, including any partial month, elapsed in the vesting period divided by 12.

&nbsp;&nbsp;&nbsp;&nbsp;

1)Termination shall be deemed to be "without cause" unless the Board of Directors of the Company, or its management designee, in good faith determines that termination is because of any one or more of the following, in which case such termination shall be deemed to be "for cause":

The Grantee's:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;fraud;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;misappropriation of funds from the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;commission of a felony or of an act or series of acts which result in material injury to the business reputation of the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;&nbsp;&nbsp;&nbsp;commission of a crime or act or series of acts involving moral turpitude;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;&nbsp;&nbsp;&nbsp;commission of an act or series of repeated acts of dishonesty that are materially inimical to the best interests of the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi)&nbsp;&nbsp;&nbsp;&nbsp;willful and repeated failure to perform Grantee's duties, which failure has not been cured within fifteen (15) days after the Company gives notice thereof to the Grantee;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii)&nbsp;&nbsp;&nbsp;&nbsp;material breach of any material provision of an employment agreement, if any, which breach has not been cured in all substantial respects within ten (10) days after the Company gives notice thereof to the Grantee; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii)&nbsp;&nbsp;&nbsp;&nbsp;failure to carry out the reasonable directions or instructions of the Grantee's superiors, provided the directions or instructions are consistent with the duties of the Grantee's office, which failure has not been cured in all substantial respects within ten (10) days after the Company gives notice thereof to the Grantee.

Provided, however, the Company's obligation to provide notice and an opportunity to cure, pursuant to subsections 3(d)(vi) – (viii) above, shall only apply to the Grantee's first breach, first failure to perform, or first failure to follow directions, as the case may be, of the nature giving rise to the right of the Company to provide notice thereof.

2)In addition, termination shall be deemed to be "without cause" if the Grantee voluntarily terminates Grantee's employment with the Company, and such termination if:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)the Company reduces the Grantee's title, responsibilities, power or authority in comparison with Grantee's title, responsibilities, power or authority on the date hereof;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)the Company assigns the Grantee duties which are inconsistent with the duties assigned to the Grantee on the date hereof and which duties the Company persists in assigning to the Grantee despite the prior written objection of the Grantee; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)the Company reduces the Grantee's annual base compensation (unless such decrease is proportionate with a decrease in the base compensation of the officers of the Company as a group), or materially reduces Grantee's group health, life, disability or other insurance programs, Grantee's pension, retirement or profit-sharing benefits or any benefits provided by the Company, or excludes Grantee from any plan, program or arrangement, including but not limited to bonus or incentive plans.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;Upon any change in the number or kind of outstanding Common Shares of the Company by reason of a recapitalization, merger, consolidation, reorganization, separation, liquidation, share split, share dividend, combination of shares or any other change in the corporate structure or Common Shares of the Company, the Company, by action of the Committee, is empowered to make such adjustment, if any, in the number and kind of Phantom

------

Shares subject to this Agreement as it considers appropriate for the protection of the Company and of the Grantee.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;&nbsp;&nbsp;&nbsp;No later than the date as of which an amount first becomes includable in the gross income of the Grantee for federal income tax purposes with respect to the Phantom Shares granted hereunder, the Grantee shall pay to the Company, or make arrangements satisfactory to the Committee regarding the payment of, any federal, state or local taxes of any kind required by law to be withheld with respect to that amount. The making of that payment or those arrangements is a condition to the obligations of the Company under the Plan, and the Company and its subsidiaries and affiliates may, to the extent permitted by law, deduct any taxes from any payment of any kind otherwise payable to the Grantee.

&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;&nbsp;&nbsp;&nbsp;Nothing in this Agreement shall affect in any manner any conflicting or other provision of any other agreement between the Grantee and the Company. Nothing contained in this Agreement shall limit whatever right the Company might otherwise have to terminate the employment of the Grantee.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;&nbsp;&nbsp;&nbsp;The laws of the State of Ohio govern this Agreement, the Plan and the Phantom Shares granted hereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.&nbsp;&nbsp;&nbsp;&nbsp;This Agreement shall be binding upon Grantee, Grantee's legal representatives, heirs, delegates and distributes, and upon the Company, its successors and assigns.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.&nbsp;&nbsp;&nbsp;&nbsp;Nothing in this Agreement shall affect the right of the Company (or any subsidiary thereof) to terminate the employment of the Grantee at any time for any, or no, reason, or confer upon Grantee the right to continued employment with the Company (or any subsidiary thereof).

IN WITNESS WHEREOF, the Company has caused its corporate name to be subscribed by its duly authorized officer as of the 31<sup>st</sup> day of January, 2026.

**STONERIDGE, INC.**

By <u>/s/ James Zizelman&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>

&nbsp;&nbsp;&nbsp;&nbsp;James Zizelman

The foregoing is hereby accepted.

[[SIGNATURE]] &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

[[SIGNATURE_DATE]]

## Exhibit 31.1

**EXHIBIT 31.1**

<u>CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES–OXLEY ACT OF 2002</u>

I, Natalia Noblet certify that:

(1)I have reviewed this Quarterly Report on Form 10-Q of Stoneridge, Inc. (the "Company");

(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;

(4)The Company's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a – 15(f) and 15d – 15(f)) for the Company and we have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the Company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the Company's internal control over financial reporting that occurred during the Company's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting;

(5)The Company's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company's auditors and the audit committee of the Company's board of directors:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company's internal control over financial reporting.

---

| |
|:---|
| /s/ Natalia Noblet |
| Natalia Noblet, President and Chief Executive Officer |
| May 15, 2026 |

---

## Exhibit 31.2

**EXHIBIT 31.2**

<u>CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES–OXLEY ACT OF 2002</u>

I, Robert J. Hartman Jr., certify that:

(1)I have reviewed this Quarterly Report on Form 10-Q of Stoneridge, Inc. (the "Company");

(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;

(4)The Company's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a – 15(f) and 15d – 15(f)) for the Company and we have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the Company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the Company's internal control over financial reporting that occurred during the Company's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting;

(5)The Company's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company's auditors and the audit committee of the Company's board of directors:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company's internal control over financial reporting.

---

| |
|:---|
| /s/ Robert J. Hartman Jr. |
| Robert J. Hartman Jr.<br>Interim Chief Financial Officer and Treasurer |
| May 15, 2026 |

---

## Exhibit 32.1

**EXHIBIT 32.1**

<u>CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</u>

I, Natalia Noblet, President and Chief Executive Officer of Stoneridge, Inc. (the "Company"), certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)the Quarterly Report on Form 10-Q of the Company for the three months ended March 31, 2026 ("the Report") which this certification accompanies fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| /s/ Natalia Noblet |
| Natalia Noblet, President and Chief Executive Officer |
| May 15, 2026 |

---

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

## Exhibit 32.2

**EXHIBIT 32.2**

<u>CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</u>

I, Robert J. Hartman Jr., Interim Chief Financial Officer and Treasurer of Stoneridge, Inc. (the "Company"), certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)the Quarterly Report on Form 10-Q of the Company for the three months ended March 31, 2026 ("the Report") which this certification accompanies fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| |
|:---|
| /s/ Robert J. Hartman Jr. |
| Robert J. Hartman Jr.<br>Interim Chief Financial Officer and Treasurer |
| May 15, 2026 |

---

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

<br>